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3’ end of the nef gene resulting in a longer nef protein isoform. There were some issues 
reviewers posed before it could be published, and Dr. Premadasa was no longer around to be able 
to address the concerns, so my contributions to this manuscript involved a Western blot probe of 
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1.1 Selenoproteins and their interest concerning viral/host interactions 
Selenoproteins are a class of proteins important for various functions in the body. They are 
essential components in a variety of redox reactions in the cell and have cell 
maintenance/homeostasis functions, as well as play a key role in immune response [6, 7]. In 
comparison with other mammalian cellular proteins, selenoproteins are unique in that they have a 
co-translational insertion of a rare amino acid called selenocysteine. Selenocysteine is similar to 
cysteine in the exception that instead of a sulfur component in the sidechain of the amino acid, 
there is a selenium ion [8]. The biosynthesis of selenocysteine starts with the charging of the 
tRNA for selenocysteine, tRNAsec. This tRNA gets charged initially with serine by the seryl-
tRNA synthetase. This is not an efficient or perfect process, with this only occurring correctly in 
the human system about 10% of the time. The now charged seryl-tRNAsec can be converted to 
selenocysteyl-tRNAsec by using selenophosphate as a donor [9]. Bioavailable forms of selenium 
coming from the diet/environment like sodium selenite can also act as a donor for this process, 
hence correlating to an increase in selenoprotein expression in mammals with excess selenium in 
their diets [10]. Once all of this has occurred, the tRNAsec gets co-translationally inserted into a 
mRNA coding for a selenoprotein at a highly conserved UGA stop codon. This is able to occur 




highly conserved nucleotides in their 3’ Untranslated Regions (UTR) called a Selenocysteine 
Insertion Sequence Element (SECIS Element). The SECIS Element forms a conserved hairpin 
loop that recruits specialized binding protein SECIS Binding protein, which then recruits an 
elongation factor for selenocysteyl-tRNAsec. All of this allows the ribosome to readthrough the 
UGA stop codon during translation of a selenoprotein and treat it as the codon and insertion site 
for a selenocysteine amino acid (Figure 1) [4, 11, 12]. This is an incredibly special process, 
because not only do all of these factors have to come together, but the stop codon has to be the 
UGA stop codon. There are three stop codons in total including the UGA stop codon; UAA and 
UAG are not recognized as a potential selenocysteine insertion sites [11]. Due to all these 
factors, selenoprotein expression can be considered a complex, highly regulated and important 
process in the cell. Selenoproteins have been shown to be vital to cellular function. Cells that do 
not express selenoprotein Thioredoxin Reductase 1 (TXNRD1) undergo apoptosis [13]. 
Glutathione Peroxidase 1 (GPx-1) has been shown to be vital for immune response against 
viruses [14]. Selenoprotein expression increases when there are more Reactive Oxigenated 
Species (ROS) in the cellular environment in order to maintain homeostasis [14]. Selenoprotein 
P is the main source of selenium and selenium transport in mammalian systems, and several 
severe neurological conditions are related to or compounded by selenium deficiencies or total 
inability to express if fully [15-18]. So, we know that not only is the translation of selenoproteins 
complex involving multiple components that need to come together, but we also know that their 
expression is vital for cell and organism health. Due to the role selenoproteins play in viral 
response of the cell, it is not surprising that evidence surrounding viral interactions with 
selenoprotein mRNA’s, and the effects viruses and selenoproteins have on each other in a host 

















1.2 Viral Impacts 
Viruses are a diverse group of microorganisms that have the potential to wreak havoc on a global 
scale and dramatically shift cultural norms and world economies. Viruses have played a key role 
in placing us where we currently reside in the world today and continue to impact where we are 
going to go and when. The examples of this are vast and too involved to fully delve into here, but 
just a few examples involve the Black Plaque wiping out a third of the European population [22]. 
Figure 1: Post-translational insertion of a selenocysteine via SECIS Element recruitment of SECIS Binding 
Protein, EF Sec, and tRNAsec. When an mRNA coding for the expression of a selenoprotein gets translated, the 
conserved SECIS Element in the 3’ UTR region (black) forms a secondary structure that recruits binding proteins 
(green and light blue) that incorporate tRNAsec (orange) and allow the UGA stop codon (red) to be read through as a 
selenocysteine codon and continue on with protein translation versus stopping translation. 5’ end of mRNA has been 
fed through the ribosome (gray), and random tRNA’s (dark blue and purple) are in the P and A sites respectively in 




The first English settlers unleashing smallpox on the New World, and in the process decimating 
Native American populations and paving the way for British colonies [23]. Haunting images of 
hospital rooms filled with iron lungs as many individuals battled the last stages of rampant Polio 
infection still are printed in our history books [24]. The 1918 Spanish Flu had an immense 
impact on civilization at a global scale. Some historians even speculate that it may have tipped 
the outcome of World War I, as it affected the armies of Germany earlier and more virulently 
than their Allied opponents [25]. Cultural scars resulting from the HIV/AIDS epidemic in the 
1980s and the millions left dead due to ignorance and bigotry over the virus still remain in the 
LGBTQ+ community. The Ebola outbreak rampaging Africa with terrifying mortality rates and 
symptomology from 2014-2016 [26]. Zika infection continues to spread through the Americas, 
and the secondary complications associated with it are devastating and currently, the only way to 
avoid them is to avoid areas with known cases of Zika infection [27]. These are just a few of the 
more famous viral historical events that have shaped our current global positions. Viruses get 
passed to us in the air, through our food, through animals/insects and through our gatherings with 
each other. We cannot avoid them. Even without including the current COVID 19 pandemic, the 
global impact viruses have and how they have shaped modern day society and practices is 
undeniable; and this current pandemic has not only completely annihilated our sense of normalcy 
today, but an entire generation is growing up isolated/remote because of it. We have no way of 
understanding how that will affect the cultural landscape in the future as these pandemic children 
enter adulthood. Specifically, for this paper, we will be talking about 2 viruses, Zika Virus 
(ZIKV) and the Human Immunodeficiency Virus (HIV). What we are currently going through 
with the COVID 19 pandemic serves as a period to a long argument history has written us on 




and lives.  We need to understand how viruses interact with humans on a molecular level to 
improve identification of viral infection, reduce the infection rate and severity of infection, and 
to prevent infection/transmission to protect future generations. 
1.3 Viruses and their survival strategies 
Viruses are among some of the smallest microorganisms characterized today. They consist of a 
relatively small genome encoding usually no more than 10-30 genes, although some viruses do 
have larger genomes. Viral genomes can either be DNA or RNA based, and these genomes can 
be protected by a collection of glycoproteins and fatty acids called a viral envelope, but this is 
not always the case. An envelope aids in the virus binding to and entering cellular membranes 
through membrane bound proteins and receptors [28]. For RNA based viruses, they can either be 
positive sense or negative sense oriented. Positive strand RNA based viruses can be translated 
into a long viral polypeptide shortly upon infection into the cell. Negative strand viruses have to 
be converted into DNA, then RNA using viral reverse transcriptase before they can be translated 
into viral proteins [29]. Due to the fact that viruses have such small genomes, they don’t have the 
capacity to express proteins on their own that they would need like cytoskeletal proteins such as 
Beta-actin or their own ribosomes. Without the exploitation of pre-existing host cellular proteins 
and processes, viruses would not be able to propagate themselves and would cease to exist as we 
understand them today [28]. Viruses also employ various strategies within their nucleotide 
sequences, enabling them to extend their genetic code past what it would seem capable of 
expressing. There are 3 reading frames for genetic code, the -1, 0, and +1 reading frames. 
Viruses utilize a phenomenon called frameshifting during ribosomal translation so that they can 
change the reading frame the ribosome reads as it translates the viral RNA into a viral 




[30, 31]. They are able to manage this a few different ways, one being conserved slippery 
sequences (tandem adenine or uracil nucleotides (UUUAAA) which do not interact as strongly 
with the ribosome) allowing the ribosome to “slide” into a +1 reading frame, and another being 
strongly conserved nucleotide regions in the 3’ UTR of the viral RNA. These conserved regions 
form complex secondary structure that is vital to the virus in many ways, one being creating 
steric hinderance for the ribosome, which can push it into a -1 frameshift [32, 33]. Figure 2 
shows what this would look like. Some proteins in viruses aren’t even able to be expressed 
without a frameshift, as is the case with one of the viruses discussed in this dissertation, HIV-1. 
Without a frameshift into the -1 reading frame, HIV-1 wouldn’t have the capacity to express pol 
gene products, which are critical for the synthesis and integration of viral DNA into the host 
genome and the generation of capsid proteins [34]. With flaviridae family of viruses (of which 
the other virus of topic in this dissertation, Zika, is a member of), their conserved secondary 
structure in the 3’ UTR in their genomes allows for host cell rnase Xrn1 to pause, which allows 
the non-degraded remains of their genome to break free in the form of subgenomic flaviridae 
RNA (sfRNA). This goes on to help the virus avoid host cell immune degradation by interfering 
with interferon generation and response. Antisense interactions between host cell mRNA and 
viral RNA are also a strategy employed by viruses to knockdown host cell protein expression 
that would aid in a viral immune response [35-38]. In this dissertation, evidence is provided that 
antisense interactions between viral RNA’s and host cell mRNA’s can also allow for stop codon 
UGA readthrough. There is mounting evidence to suggest that viruses employ these antisense 
interactions especially with regards to selenoprotein mRNA’s in order to utilize host cell 
selenoprotein translational machinery to insert their own selenocysteines co-translationally into 




could be happening in ZIKV infected or HIV-1 infected cells. These strategies seem esoteric and 
random with minimal rates of success but seem to have huge effects on viral proliferation and 
virulence, hence why the nucleotide regions associated with these various viral hacks are so 
heavily conserved across viral strands. 
 
Figure 2: Viral strategies utilized to create extensions on translated proteins past UGA stop codons. 
Visualization of possible protein products that a stop codon readthrough could yield. The top strand of mRNA is 
being read by the ribosome in the 0 reading frame where the ribosome (blue/green) reads the stop codon (red) as 
a stop codon and translates the protein (yellow) coded by that mRNA. In the middle panel, the ribosome 
translates the same mRNA, only a frame-shifting event has happened that has caused the ribosome to slip back 
in the -1 reading frame (black arrow) so that the stop codon (red) will no longer read as a stop codon but as a 
codon for an amino acid. The bottom panel is the result of the new elongated protein (yellow/purple) that was 
able to be translated by the ribosome once it was frame-shifted out of the 0 reading frame which allowed it to 


















Figure 3: Visual into theorized utilization of host selenoprotein translation machinery to synthesize viral 
selenoprotein. The green RNA species is viral RNA and the red RNA species is a host cell selenoprotein 
mRNA. Visualized in red is a highly conserved UGA stop codon just after a viral gene and before the 3’UTR of 
the viral RNA. The hair pin loop at the 3’ end of the selenoprotein mRNA represents a SECIS unit, which has 
already recruited SECIS Binding Protein, EF Sec, and tRNAsec. Here the viral RNA is interacting in an antisense 
fashion in a highly selective manner in order to use the mammalian selenoprotein translational machinery to 





INHIBITION OF SELENOPROTEIN SYNTHESIS BY ZIKA VIRUS MAY 
CONTRIBUTE TO CONGENITAL ZIKA SYNDROME BY MIMICKING SEPP1 
KNOCKOUT AND GENETIC DIEASE PCCA 
 
Gabrielle P. Daileya, Ethan W. Taylora, Jan A. Ruzickab 
aDepartment of Chemistry and Biochemistry, University of North Carolina at Greensboro, 435 
Patricia A. Sullivan Science Building, PO Box 26170, Greensboro, NC 27402-6170, United 
States of America. bDepartment of Basic Pharmaceutical Sciences, Fred Wilson School of 
Pharmacy, High Point University, One University Parkway, High Point, NC 27268, United 
States of America. 
2.1 Abstract 
Selenium status plays a major role in health impacts of various RNA viruses. We recently 
reported potential antisense interactions between viral mRNAs and host mRNAs of the 
antioxidant selenoprotein thioredoxin reductase (TR). Here, we examine possible targeting of 
selenoprotein mRNAs by Zika virus (ZIKV) as a pathogenic mechanism, because microcephaly 
is a key manifestation of Progressive Cerebello-Cerebral Atrophy (PCCA), a genetic disease of 
impaired selenoprotein synthesis. Potential antisense matches between ZIKV and human 
selenoprotein mRNAs were initially identified via nucleotide BLAST searches, using ZIKV 
genomic RNA as a probe. The strongest antisense matches of ZIKV regions, against human 
TXNRD1 and selenoprotein P (SePP1), were validated by algorithms for prediction of RNA 




Western blot probe for SePP1 and TXNRD1 expression as well as RT-qPCR analysis was 
conducted on non-ZIKV infected and ZIKV infected cells and effects of selenium 
supplementation on any protein or mRNA change in SePP1 and TXNRD1 expression upon 
ZIKV infection was observed. Computationally, ZIKV has regions of extensive (~30bp) and 
stable (ΔE < −50kcal/mol) antisense interactions with mRNAs of both TXNRD1 and SePP1, a 
selenium carrier protein essential for delivery of selenium to the brain. The ZIKV/SePP1 
hybridization was experimentally confirmed at the DNA level using synthetic oligonucleotides to 
ensure that the proposed interaction between ZIKV RNA and SePP1 mRNA was possible in 
vitro. ZIKV infection was shown to knock down SePP1 expression by 99.1% and TXNRD1 
expression by 90.4% in ZIKV infected cells. Selenium supplementation seemed to have little 
effect on any TXNRD1 or SePP1 protein expression in the presence of ZIKV infection. SePP1 
mRNA increases by 6 folds upon infection of ZIKV, and TXNRD1 mRNA increases nearly 8 
fold with ZIKV infection and selenium supplementation. These findings provide more insight 
into how ZIKV infection can lead to microcephaly onset and how viral RNA and host cell RNA 
interactions serve as a key strategy for viral inhibition of host cell viral immune responses. 
2.2 Introduction 
Zika virus (ZIKV) is an enveloped, positive sense, RNA based virus, and was first isolated near 
the Zika forest by Lake Victoria in Uganda, Africa.                                                                 
ZIKV is a member of the flaviridae family of viruses; the viruses associated with Dengue fever, 
yellow fever, and Japanese encephalitis are also flaviridae family members. ZIKV is an 
arborvirus meaning a large part of its transmission route is through the bite of an aedes mosquito 
(A. aegygpti, A. albopictus, A. africanus, and A. luteocephalus), but it can also be transmitted 




fetus. Symptoms of ZIKV infection tend to be relatively mild for the majority of healthy, non-
immunocompromised adults; but can include fever, fatigue, myalgia, headaches, rashes, 
conjunctivitis and retro-orbital pain [42, 43]. Where ZIKV becomes a larger concern is in regard 
to the secondary conditions that have been associated with infection including Guillain-Barre 
syndrome in adults and ZIKV congenital microcephaly in infants whose mothers contracted the 
virus during pregnancy.  
Guilian-Barre syndrome is an autoimmune condition that is characterized by the afflicted 
individuals immune system attacking the myelin sheath surrounding the axons to their neuronal 
cells, leading to symptomology including limb paralysis, bilateral facial palsy and autonomic 
dysfunction with sustained ventricular arrythmia, hypotension, seizures, general motor-cortex 
degeneration, and at times death [42].  
Figure 4: Comparison of phenotypes of PCCA and ZIKV congenital microcephaly. Panel 1 shows 
MRI of child with PCCA and demonstrates reduced cranial circumference and compression to the 
brain along with abnormal development [1]. Similar in phenotype and symptomology, Panel 2 shows 




This condition is not always reversible, and the afflicted individual could be affected for the 
duration of their lives. ZIKV congenital microcephaly is the focus of this chapter. Microcephaly 
is defined as a clinical condition where the infant head circumference is significantly smaller 
than what is normal and is considered a severe congenital defect. Two generalized forms of 
microcephaly are recognized, one being diagnosed around 32 weeks of the gestation period and 
characterized by a decrease in neuron production, and the other characterized by a lack of head 
growth after birth due to loss of dendritic connections [43-47]. A 2012 study also linked the 
depletion of radial glial cells and neuronal stem cells (neuronal progenitor cells) via cell death or 
premature differentiation to microcephaly onset in utero [48]. A rare genetic disease that causes 
microcephaly is Progressive Cerebello-Cerebral Atrophy (PCCA). It is an autosomal recessive 
syndrome characterized by profound mental retardation and severe quadriplegic spasticity, and 
its cause is a defect in selenium metabolism. Specifically, the mutations responsible for this 
disease were found to be in the SepSecS gene, which encodes O-phosphoseryl-
tRNA:selenocysteinyl-tRNA synthase, a selenium transferase that catalyzes the final step in the 
biosynthesis of Sec. Unique among the amino acids, Sec is synthesized while bound to its 
cognate tRNA, by conversion of O-phosphoseryl-tRNASec to selenocysteinyl-tRNASec. 
Homozygous individuals, lacking a functional copy of SepSecS, have therefore lost the unique 
catalytic benefits of Sec in selenoenzymes, at best having a serine hydroxyl group in place of the 
selenol of an active site Sec, leading to a drastic or total loss of catalytic activity in thioredoxin 
reductases, Se-dependent glutathione peroxidases, iodothyronine deiodinases, and other human 
selenoproteins.  [1, 44]. This means that they lack the ability to synthesize any selenoproteins, 
which are a class of proteins fundamentally important for immune response, redox reactions, and 




Zika related microcephaly onset is most critical during the first trimester but usually isn’t 
diagnosed until the second trimester and occurs when a pregnant individual becomes infected 
with ZIKV and vertically transmits it to the fetus in utero [42]. Symptoms include profound 
mental retardation and severe quadriplegic spasticity like PCCA. The exact mechanism of 
vertical transfer from mother to fetus is still not fully characterized, but ZIKV has both been 
shown to infect/be isolated from placental cells, amniotic fluid and fetal brain cells including 
multipotential neuronal progenitor cells and glial cells [51-54]. Zika related microcephaly is 
sometimes not diagnosed until after birth, which could be due to more stringent screenings and 
diagnostic measures being needed, or post-utero ZIKV infection perinatally through breast 
feeding [55, 56]. There is not a clear answer currently in the literature as to why ZIKV infection 
leads to the onset of microcephaly in some ZIKV+neonates, but it is the goal of this chapter to 
address some gap in the knowledge surrounding this phenomenon.  
In this chapter, a case is made linking the symptomology and cause of PCCA to ZIKV congenital 
microcephaly. PCCA and ZIKV congenital microcephaly have remarkably similar phenotypes 
and consequences for the afflicted individuals (Figure 4). As stated, PCCA is caused by a 
complete lack of ability to express any selenoproteins; and through bioinformatic methods, our 
group identified two predicted antisense regions of interaction between ZIKV RNA and host cell 
selenoprotein mRNA coding for the expression of both Selenoprotein P (SePP1) and 
Thioredoxin Reductase 1 (TXNRD1) (Figure 5). SePP1 is predominately secreted from the liver 
but is expressed in many tissues throughout the body, and it is the sole source of selenium 
transport throughout the body [6, 57, 58]. SePP1 has 10 selenocysteine residues and transports 
selenium to the brain by binding the Apo2ER receptor, where it will then get broken down in the 




in the body for the continued synthesis of tRNAsec [15, 59]. SePP1 protein expression 
knockdown has been linked to several neurological conditions in mouse models including neuron 
degeneration, brain stem deterioration, seizures, and death [59]. Neuronal cells express a 
truncated isoform on SePP1 on their own, but studies have shown that mice only expressing the 
truncated isoform of SePP1 in their neuronal cells and not expressing full length SePP1 from 
their livers are more dependent on selenium in their diets and are not able to circumvent the 
negative effects of SePP1 knockout on a selenium deficient diet [60, 61]. TXNRD1 is part of the 
enzymatic chain that converts RNA sugars to DNA sugars. It is essential for cell homeostasis, 
and when TXNRD1 knockdown is seen in cell lines, apoptosis is induced. TXNRD1 is expressed 
7 times more in fetal multipotential neuronal progenitor cells than it is in adults and is also 
essential for cell differentiation [62, 63].  
Like the majority of other viruses, ZIKV has a relatively small genome (10,794 ribonucleotide 
bases) encoding for only 10 genes (3 structural and 7 non-structural proteins). As discussed, 
viruses often employee various methods to get the biggest translational/expression payload from 
their relatively modest genomic bank including hijacking host cell machinery or by employing 
different reading frames, secondary RNA structures, frame shifts or alternative splicing [2]. 
Antisense interactions between viral RNA and host cell mRNAs are a characterized tactic that 
viruses employee to further interfere with host cell protein expression. Our group has identified 
two antisense regions of predicted high affinity interaction between SePP1 mRNA (the predicted 
interaction on the exon can be extended 30 nucleotides in the 3’ direction to span an intron/exon 
junction in SePP1 pre-mRNA as well seen in Figure 5) and TXNRD1 pre-mRNA (spanning an 
intron only seen in Figure 5). Since members of the flaviridae family of viruses can replicate in 




knocking down protein expression of TXNRD1 and SePP1 [54, 64]. The proposed antisense 
interactions are occurring between these host cell RNA species and the 3’ Untranslated Region 
(UTR) of ZIKV RNA. Flaviridae viruses have conserved nucleotide sequences in their 3’ UTR 
that form highly conserved pseudoknot secondary structures. They employ this tactic to slow 
down host cell degeneration of the foreign viral RNA by host cell rnase Xrn1. The secondary 
structure in the 3’ UTR of the viral RNA causes the rnase to pause, releasing the remaining non-
degraded viral RNA into the cytosol. This subgenomic flaviviral RNA (sfRNA) interferes with 
host cell interferon production and increases viral propagation by lowering cell viral defense 
mechanisms [35, 36, 38, 65-67]. Hence, the proposed antisense interactions could be favorable 
for ZIKV proliferation in the cell. Here, a case is made that predicted antisense interactions 
(Figure 5) between ZIKV RNA and SePP1 mRNA and TXNRD1 pre-mRNA are occurring in 
ZIKV infected cells, and that this interaction is interfering with the already complicated 
selenoprotein expression complex, thus knocking down expression of these two proteins. Due to 
their vital function for neuronal development and maintenance to the fetus, the knockdown of 























Figure 5: Predicted antisense interactions 
between Zika virus mRNA and regions 
either in introns or spanning RNA slice sites 
of human selenoprotein mRNAs  
A: The hybrid dsRNA secondary structure 
shown, and computed interaction energy were 
generated using the RNAHybrid 2.2 program.  
When used as a query vs. the entire SePP1 
mRNA, the illustrated (green) 54 base region 
of Brazilian ZIKV strain SPH2015 (bases 
9706-9759) yields the match shown as the 
minimum free energy (MFE) antisense 
interaction, to a (red) 47-base region of SePP1 
(bases 541-587; these sequence ranges include 
the unpaired single base overhangs shown at 
each end). 
B: Spanning an intron/exon junction of SePP1. 
Flaviviruses like ZIKV replicate in the nucleus 
as well as in the cytosol, meaning ZIKV 
mRNA could also have the opportunity to 
interact with unspliced cellular pre-mRNAs. 
The ZIKV/SePP1 interaction shown Panel A 
can be extended by another ~30 bases at the 3’ 
end of the ZIKV sequence, into an intron of   
SePP1, which is the interaction shown in this 
panel. The   black arrow indicates the 
intron/exon boundary in SePP1. The right side 
of the structure pictured here is identical to the 
structure shown in Panel A, only rotated 
counterclockwise.  Formation of such a 
structure might inhibit the splicing and 
maturation of SePP1 mRNA. An essentially 
identical antisense complex is predicted using 
the IntaRNA progam, differing only in that the 
terminal 7 base pairs at the bottom of the 
structure shown above are not included in the 
IntaRNA prediction (Appendix A, Figure 22). 
C: Targeting an intron of TR1:  Both the 
RNAHybrid and IntaRNA programs predict 
the antisense interaction shown here between a 
3’ noncoding region of ZIKV mRNA (near the 
beginning of the well documented non-coding 
“subgenomic Flavivirus RNA” region) and an 
intron of TR1.  An identical antisense complex 





2.3 Materials and methods 
2.3a Computational methods for identification of virus-host RNA antisense interactions  
 Potential antisense matches between regions of ZIKV and host selenoprotein mRNAs were 
initially identified via nucleotide BLAST searches (http://blast.ncbi.nlm.nih.gov/Blast.cgi). A 
complete 2015 Brazilian ZIKV genomic mRNA sequence (see following section) was used as a 
probe for Nucleotide BLAST (blastn option) with default search parameters, initially against the 
Reference RNA sequence database (refseq.rna), restricted to Homo sapiens (taxid:9606) with 
selenoprotein as a search term. Because ZIKV is known to replicate in the nucleus, the search 
was later extended to include genomic sequences (corresponding to unspliced RNA; see below). 
The initial mRNA search led to the identification of the core region of the antisense match to a 
coding region of SePP1 mRNA shown in Figure 5. The RNAHybrid program 
(http://bibiserv2.cebitec.uni-bielefeld.de/rnahybrid) was then used to assess the match using an 
algorithm and parameters designed for actual RNA:RNA interactions, and to  investigate the 
possibility that, with some mismatches and bulges characteristic of dsRNA, the match at the 
RNA level might be extended in the 5’ and 3′ directions beyond the core region identified by 
BLAST [68]. A more stringent method for accurate prediction of RNA-RNA interactions was 
then applied: the IntaRNA program (http://rna.informatik.uni-freiburg.de/IntaRNA/Input.jsp) 
[68-70]. This algorithm factors in not only the hybridization energy of the interacting pair of 
RNAs, but also takes into consideration the “unfolding energy” required to overcome and 
outweigh the stability of any internal RNA secondary structures within the two individual RNA 
strands. The program will only identify a match if the net inter-strand binding energy is 
substantially lower (i.e., more stable) than the sum of the internal folding energies of the 




supported by the program) IntaRNA was in each case able to identify as the single most 
significant match an antisense interaction that was essentially identical to that found by the 
combined BLAST-RNAHybrid approach.  
2.3b Reference sequences used in antisense sequence analysis and oligonucleotide design 
The ZIKV Brazilian strain SPH2015, Genbank accession number KU321639, was used as a 
reference sequence for ZIKV, as it was the only complete Brazilian genomic sequence available 
at the time the study was initiated. Using methods described below, the most significant 
antisense match found to a region of a human selenoprotein was to selenoprotein P (SePP1). The 
initial SePP1 hit was to a region of mRNA common to all of its transcript variants; the sequence 
numbering used in the figures and text is from transcript variant 6 (the longest variant), Genbank 
# NM_005410.2. Because the antisense match to the SePP1 mRNA was at the very beginning of 
an exon, to explore the possibility that this match might extend into the upstream intron in 
unspliced RNA, that search was repeated using genomic DNA instead of the mRNA database, 
leading to the identification of an extended match spanning the intron-exon boundary in the 
SePP1 genomic sequence, Genbank DQ022288.1.  An antisense match of a 3’ noncoding region 
of ZIKV to an intron of thioredoxin reductase 1 (TXNRD1) was also identified in the search vs. 
human genomic DNA; the TXNRD1 sequence numbering used in the figures and text is from the 




2.3c Experimental confirmation of the predicted ZIKV-SePP1 antisense interaction at the 
DNA level 
An electrophoretic mobility shift assay was used to confirm the predicted interaction shown in 
Figure 5 via demonstration of in vitro DNA hybridization of the cognate ZIKV:SePP1 pair of 
sequences. The procedure was essentially as described previously [2]. Briefly, synthetic single 
stranded ssDNA oligomers (Integrated DNA Technologies, Inc., Coralville, IA) were obtained, 
corresponding precisely to the ZIKV and SePP1 sequence fragments shown in Figure 5. An 
additional oligo with a random sequence of identical base composition to the SePP1 fragment 
was used as a control. Prior to gel electrophoresis, oligos (~1 μg each in 10 μl PBS), either singly 
or in all three possible pairs, were incubated at 37°C for 15 hours, followed by cooling to room 
temperature over 1 hour. See legend to Fig. 1 for details about the arrangement of lanes on the 
gel.  Bands were separated on a 4% agarose gel and visualized using ethidium bromide (Figure 
6).  
Figure 6: Target-specific in vitro DNA hybridization of the predicted ZIKV-SePP1 antisense pairing. 
Confirmed at the DNA level by gel shift assay, using DNA oligonucleotides corresponding exactly to the 
sequences Figure 5. The left three lanes contain only a single (unpaired) ssDNA oligo, as follows: Zika=the 54 
base fragment from Figure 5, SePP1=the 47 base fragment from Figure 5, Random=a 47 base randomly 
shuffled version of the SePP1 fragment. The right 3 lanes are from incubations of pairwise combinations of 
those 3 oligos: Zika+SePP1 (Z+S), Zika+Random (Z+R) and SePP1+Random (S+R). Of these, only the 
Zika+unshuffled SePP1 hybridize to form a slower moving dsDNA band that migrates as expected for ~50bp 
dsDNA (size markers not shown; for dsDNA ladder, see original uncropped gel photo, Fig.S5 in online 
Supplemental Materials). The Z+R and S+R combinations still migrate as single stranded DNA, demonstrating 




2.3d Cell Culture 
Cell culture media was prepared by combining 444.5 mL of 1x DMEM media (GibcoTM catalog 
number 11054020), 50 mL heat-inactivated FBS (GibcoTM catalog number 10082147), 5 mL 
100X L-glutamate (Invitrogen catalog number 25030081), 500 uL Penicillin-Streptomycin 
(GibcoTM catalog number 15070063) and filtering it through a 0.22 micron combined 
filter/container apparatus. HEK 293T cells were defrosted from original ATCC stock and 
resuspended in 5 mL of cell culture media in a T25 flask (vented breakneck flask) and allowed to 
come to confluency over the course of 2 weeks at 370C and 5% CO2. 1X PBS washes and media 
changes were performed during this growth cycle every 3 days. Once cells reached 70-90% 
confluency, the cells were passaged by incubating 1 mL of TrypLETM Express Enzyme (1X, no 
phenol red, GibcoTM catalog number 12-604-013) on the cell monolayer at 370C and 5% CO2 for 
5 minutes. 1 mL of cell culture media was added to deactivate the TrypLETM Express Enzyme 
and the cell mixture was centrifuged at 1,800 rcf for 4 minutes at room temperature. The 
resulting cell pellet was resuspended in 1 mL of cell culture media. 10 uL was removed from the 
new cell mixture and added to 10 uL of 0.4% Trypan blue solution (GibcoTM catalog number 
15250061). 10 uL of the resulting solution was analyzed on the CountessTM II (InvitrogenTM 
catalog number AMQAX1000) for cell viability and cell count calculations. 4 aliquots of 1 x 105 
cells were removed from the cell mixture and seeded into 4 separate T25 flasks and allowed to 
grow under the same conditions previously specified until the cell monolayer reached 20-30% 
confluency. Once desired confluency was reached, the 4 flasks were separated based on 
experimental conditions HEK alone (positive control), HEK with 20 nM sodium selenite 
supplementation, HEK with ZIKV infection, and HEK with ZIKV infection and 20 nM sodium 




underwent a PBS wash and 1 mL of Opti-MEMTM Reduced Serum Media (GibcoTM catalog 
number 31985070) was added to each flask and allowed to sit overnight in the 370C and 5% 
CO2. The other two experimental conditions that called for ZIKV infection were washed with 1X 
PBS and 1 mL of  ZIKV infection inoculum (MOI 0.01) was added to the cell monolayer and 
allowed to sit overnight at 370C and 5% CO2. After the overnight period, the Opti-MeM and 
ZIKV infection inoculum from their respective experimental conditions were decanted into 10% 
bleach. All experimental conditions underwent a 5 mL PBS wash. Experimental conditions 
calling for sodium selenite supplementation received 5 mL of cell culture media with a 20 nM 
concentration of sodium selenite and experimental conditions not calling for sodium selenite 
received 5 mL of cell culture media only. All experimental conditions were allowed to grow an 
additional 96 hours undisturbed at 370C and 5% CO2. After 96 hours, the cell monolayers from 
each experimental condition were harvested following the same procedure described earlier with 
the cellular passage. Cell counts were performed on all experimental conditions, and the 
resulting cell mixtures were again spun down at 1,800 rcf for 4 minutes to form a cell pellet, 
where they were stored at -800C until further processing. All cell culture was performed in a 
Labgard ES Class II, Type A2 biological safety cabinet. All cell culture surfaces were exposed to 
UV light for 15 minutes before and after work was performed. All cell culture surfaces, 
disposables, and containers were wiped down with 70% ethanol before work and where 
applicable, after work was done. All cell culture involving live ZIKV infection was performed 
with BSL2+ PPE including gloves, lab coat, and eye protection. All cell culture was exposed to 
10% bleach solution before being autoclaved at 14 PSI, 1210C for 1 hour or until autoclave 





2.3e ZIKV Infection/propagation 
PRVABC59 Zika viral stock was defrosted from original ATCC stock (VR-1843) and aliquoted 
into 10 100uL tubes and stored at -800C for future use. 100 uL of viral stock was added to 900 
uL of Opti-MeM to achieve an MOI of 0.01. The resulting inoculum was placed directed onto 
HEK 293T cell monolayer cultured as previously described. The flask was gently rocked for 5 
minutes before being placed in a separate CO2 incubator overnight at 37
0C and 5% CO2. The 
inoculum was then decanted and the cell monolayer was washed with 1X sterile PBS and 5 mL 
of cell culture media was added. The infected cells were allowed to culture undisturbed for a 
period of 96 hours, after which the cellular supernatant was collected and filtered through a 0.22 















Table 1: Primers used for amplification of RNA targets 
Quick-RNATM Miniprep kit (Zymo Research catalog number R1054) was used to extract and 
purify total RNA from cell pellets resulting from each experimental condition according to 
manufacturer’s guidelines. 3 uL of the purified RNA was removed from each sample to be tested 
for concentration, integrity, and purity via nanodrop at A254. 1 uL of SUPERase.In
TM RNase 
Inhibitor (InvitrogenTM catalog number AM2694) was added to each RNA sample. Samples were 
stored at -200C. 500 ng of RNA from each sample were pipetted into a 48 well plate in 
quadruplicate for each experimental condition (HEK lysate, HEK lysate + Se supplementation, 
ZIKV infected HEK lysate, and ZIKV infected HEK lysate + Se supplementation). This was 
repeated 3 times to allow for amplification of all RNA targets. 2 uL of 0.2 uM primer mix (Table 
RNA amplified Forward Primer in 
Primer Mix 
Reverse Primer in Primer 
Mix 
SePP1 mRNA 5’TCC TCC ATT CTA 
AAC TGC TAA TTA 
TCC3’ 
5’CCA GTG TTC TAT TTG 
CTT TAA TGA G3’ 
TXNRD1 mRNA 5’ ACT CCG GCA TTT 
GCA GCA GAG3’ 
5’ ATA AGG TCA TAG 
TCA TAG GAC TTG GG3’ 
Beta Actin mRNA 5’CAC CAT TGG CAA 
TGA GCG GTT C3’ 
5’AGG TCT TTG CGG 
ATG TCC ACG T3’ 
ZIKV RNA 5’AGA TGG AGC TTG 
TTG AAG TGG3’ 






1) was added to each well with 1 uL of SuperScriptTM IV Reverse Transcriptase (InvitrogenTM 
catalog number 18090010), and 10 uL of PowerUpTM SYBRTM Green Master Mix (Applied 
BiosystemsTM catalog number A25741). The reaction volume was brought to 20 uL with 
UltraPureTM Distilled Water (InvitrogenTM catalog number 10977-015). The well plate was 
sealed and cycled at 480C for 30 minutes for cDNA synthesis, 950C for 10 minutes for Taq 
Polymerase activication, and then cycled through 40 cycles of denaturing steps at 950C for 10 
seconds and annealing/amplification steps 540C for 30 seconds. All one-step RT-qPCR data was 
gathered and analyzed using EcoTM Real-Time PCR machine and software (Illumina catalog 
number EC_900_1001). All RNA targets (SePP1, TXNRD1, and ZIKV RNA species) were run 
in quadruplicate for each experimental condition. The quadruplicate Ct value averages and 
standard deviations were calculated in Excel. P-values  were determined by comparing 
experimental values (HEK+Se, HEK+ZIKV, HEK+ZIKV+Se) to the control HEK in a two-
sampled, 2-tailed t-Test assuming equal variance in Excel.    
2.3g Western Blots 
1 mL of cold RIPA lysis buffer (10X Millipore, catalog number 20-188, diluted to 1X with 
deionized water) was added for every 5x106 cells in the resulting cell pellets from each 
experimental condition. 10 uL of beta-mercaptoethanol, HaltTM Protease and Phosphatase 
Inhibitor Cocktail (100X, EDTA-free, Thermo ScientificTM catalog number 78441), and a 0.5 M 
EDTA solution (0.5 M EDTA in sterilized deionized water) was added to every 1 mL of cold 
RIPA lysis buffer prior to addition to the cell pellet. The cell pellet was resuspended in this 
solution and vortexed for 10 second intervals, three times each with 30 second intervals in 
between where the samples were incubated on ice. The samples were then sonicated for 15 




samples were incubated on ice. The sonicator probe was cleaned using 99% ethanol in between 
each sample to ensure no contamination between the experimental conditions. The samples were 
then placed on a 950C heating block for 5 minutes before being spun down at 16.1xg at room 
temperature for 10 minutes. The supernatant was collected and stored at -800C until further use.        
The Pierce BCA Protein Assay Kit (Thermo Scientific, catalog number 23225) was used to 
determine relative protein concentrations of each experimental sample. The assay was done to 
manufacturers specifications and visualized at 560 nm on a plate reader. Equal amounts of 
protein from each experimental condition were loaded into a 12% Mini-PROTEAN TGX SDS-
PAGE Gel (samples contained 1X PBS, protein sample, and 3 uL 10X Loading Dye (Innovating 
Science, catalog number IS5208)). 3 uL molecular weight ladder (SMOBio Enhanced 3-
colorExcelBandTM, catalog number PM2510) was added to one lane as a standard. The gel was 
set up in a BioRad Mini-PROTEAN vertical gel electrophoresis box with running buffer (10X 
Tris/glycine buffer, BioRad catalog number 1610732, diluted to 1X with deionized water) was 
added to the fill lines. An ice pack was placed in the gel box system and the setup was run at 80 
V for 10 minutes and 115 V for 50 minutes. After running, the gel was removed from its cast and 
placed in deionized water along with 4 pieces of filter paper and 1 piece of 0.45 uM pore 
nitrocellulose membrane (BioRad catalog number 1620115) cut to the size of the gel. The wet 
sandwich was placed in the BioRad wet transfer casket and filled to the top of the set up with 
transfer buffer (1X running buffer, 20% methanol). An ice pack was placed inside the apparatus, 
and the transfer was allowed to run at 200mA for 1 hour and 15 minutes. Once the transfer was 
complete, the membrane was removed from the wet transfer casket and rinsed off once in 
deionized water before being blocked in 2% milk protein solution (2% w/v dried milk with 1X 




was washed 3X for 5 minutes each with 1X sterilized PBS before addition of primary antibody 
(either monoclonal anti-SePP1 in rabbit (Sigma-Aldrich catalog number SAB2103123-100UL), 
monoclonal anti-TT1 in rabbit (BETHYL catalog number A304-791A), or polyclonal anti-beta 
Actin (proteintechTM catalog number 20536-1-AP) depending on what protein expression was 
being measured). The blot was allowed to incubate with 10mL of 1:1000 dilution (in 1X 
sterilized PBS) of the primary antibody on a shake table at 40C overnight. Following this, the 
primary antibody was removed and the blot was washed an additional 3X with 1X sterilized PBS 
for 5 minutes a piece before 10mL of 1:5000 dilution (in 1X sterilized PBS) of secondary 
antibody (goat anti-rabbit IgG (H+L) Cross-Absorbed Secondary Antibody Alexa FluorTM 700, 
Invitrogen catalog number A-12038 for SePP1 and TXNRD1 monoclonal antibodies and goat 
anti-mouse IgG (H+L) Cross-Absorbed Secondary Antibody Alexa FluorTM 700, Invitrogen 
catalog number A21036 for polyclonal beta-actin antibody) was incubated on the blot for 90 
minutes on a shake table at room temperature. The secondary antibody was removed and the blot 
was washed as previously described before being placed in sterilized 1X PBS and visualized on 
gel imager Odyssey CLx (LI-COR) excited at 700 nm with emission measured at 720 nm at the 
highest quality setting. The densitometry of the tagged protein bars on the resulting blots were 
analyzed using the gel reader software. Average protein expression for each target protein in 
each experimental condition was calculated by averaging the densitometry results of triplicate 
blots. Error bars were generated using standard error of the means and p-values were determined 
by comparing experimental values (HEK+Se, HEK+ZIKV, HEK+ZIKV+Se) to the control HEK 






2.4 Results and discussion  
2.4a Western blot data   
 











Figure 7: Western blot analysis of SePP1 Expression in ZIKV infected HEK 293T cells. A. Western blot of 
SePP1 protein expression under several experimental conditions (with or without addition of 20 nM sodium 
selenite, either ZIKV+ or ZIKV−). Equal concentrations of protein were used per sample. Lanes are designated 
in the images. Results show:  A. Anti-SePP1-labeled protein bands across experimental conditions at the 60 
kDa level, which corresponds to the predicted mass of full length SePP1 (isoform 1). Near-abrogation of SePP1 
protein expression is seen in ZIKV-infected cells.   B. Quantitative expression of SePP1 in experimental 
conditions (Y axis shows fluorescence intensity units/1000). HEK SePP1 expression starts at 43,500, increases 
to 80,100 for HEK+Se, drops to 268 for HEK+ZIKV, and increases slightly to 416 for HEK+ZIKV+Se. Error 





Western blot analysis of SePP1 expression in HEK cells (Figure 7, Panel A) show expression of 
SePP1 across all experimental conditions at the 60 kdal line. The difference in the densitometry 
data for the SePP1 expression of the different experimental conditions was converted as a 
percent change from the baseline SePP1 expression calculated from the averaged results of the 
positive control HEK lysate only condition (Table A1, Appendix A). The results presented in 
Figure 7, Panel B and in Table A1 were gathered by averaging the densitometry data from 3 
western blots running each experimental condition. A dramatic decrease in SePP1 expression is 
observed in both experimental conditions where HEK cells were infected with ZIKV, and 
densitometry analysis of the SePP1 western blot shows a 99.4% decrease of SePP1 expression in 
ZIKV infected HEK cells with SePP1 only expressing at 0.6% in ZIKV infected cells compared 
to non-infected ZIKV infected cells (Figure 7, Panel B). This is essentially a complete 
knockdown of SePP1 expression in ZIKV infected cells. There have been 4 isoforms of SePP1 
isolated from rat plasma [71-73]. All isoforms contain the first UGA selenocysteine insertion site 
in the N-terminal region of the protein, but have truncated C-terminal domains resulting with 
termination at positions of the 2nd, 3rd, and 7th UGA insertion sites, resulting in fewer 
selenocysteine being present in these isoforms and being of a lower molecular weight [58]. 
SePP1a is the full length selenoprotein and has 9 selenocysteine residues in the C-terminal 
domain, resulting in a molecular weight of 60 kdal when glycosylated and run on an SDS-PAGE 
gel, thus indicating that the results observed are of the expression of full-length SePP1 [6, 57, 
58]. Several studies have determined that selenoprotein P has a high turnover rate in not only rat 
plasma, but human plasma as well. This is in order to recycle the selenocysteine for the 
incorporation into other selenoproteins being translated in the cell [74, 75]. The efficient 




were observed in any meaningful way in the ZIKV infected experimental conditions; as the cell 
may have been recycling selenocysteine by breaking down less effective SePP1 isoforms and 
using it for the translation of more relevant selenoproteins to the cell including TXNRD1. SePP1 
is the main source of plasma selenium, and it has important functions for many tissues of the 
body [4-8]. However, studies have found that in SePP1 knockdown rats, SePP1 with isotopically 
labeled sodium selenite in the selenocysteine sites is most rapidly transported from the SePP1 
knockdown rat plasma to their brain, adding to the body of knowledge that SePP1 primary 
function is selenium transport to the brain, with any antioxidant or cell viral response functions 
coming secondary [76]. 
 Since the experiments in this paper are limited to HEK293T cells and not animal models, the 
complexities of SePP1 expression are limited, and it would stand to reason the need for 
TXNRD1 expression, or other antioxidant functioning selenoprotein expression including 
glultathione peroxidase would be favored over the expression of SePP1 in these cells, especially 
in context to cellular response against ZIKV infection. These could all be compounding reasons 
why SePP1 isoforms reported in the literature were not observed in even the HEK and HEK+Se 
conditions of these experiments in meaningful ways. The antigen for the antibody used for probe 
for SePP1 expression in all experimental conditions was the N-terminal region of the protein, 
which is present in all isoforms, so missing SePP1 isoform expression due to the antigen for the 
SePP1 antibody simply not being present in the shorter isoforms was not a variable [1-7]. These 
results also lend support to the proposed antisense interaction between ZIKV RNA and SePP1 
mRNA in the host cell. The proposed antisense interaction between these two RNA species is 
predicted to occur upstream from the first UGA selenocysteine insertion site in SePP1 mRNA, 




protein translation of any truncated isoforms of SePP1 would be highly unlikely [68-70, 77]. 
Additionally, viruses in the flaviridae family have the ability to replicate in the nuclease of the 
infected cell [64, 78, 79]. As stated, the antisense interaction proposed between ZIKV RNA and 
SePP1 mRNA could occur with the pre-mRNA form of SePP1 mRNA. This means that ZIKV 
viral RNA could be knocking down SePP1 pre-mRNA in the nucleus before it has the chance to 
enter the cytoplasm of the cell for protein translation. Additionally, a 2006 study showed that 
proteins essential for the ribosomal readthrough of the UGA stop codon to a selenocysteine 
codon, SECIS binding protein 2 (SBP2) and Specialized Elongation Factor (EFsec), both 
undergo nucleocytoplasmic shuttling through identification of export signals and 
immunohistostaining revealing both proteins colocalized within the nucleus [80].The unique 
ability of ZIKV RNA to enter the nucleus for replication and interact with pre-mRNAs like 
SePP1 mRNA could be a factor as to why no other isoforms of SePP1 are observed in ZIKV 
infected experimental conditions, in addition to ZIKV RNA having the unique ability to interfere 
with the selenocysteine insertion complex within the nuclear envelope as well as in the 
cytoplasm. This would lead to a near complete knockdown of SePP1 expression with no isoform 
expression, which is what is observed with these experiments. As stated, cellular expression of 
SePP1a is more abundant than other isoforms, so it is also possible that there was not sufficient 
SePP1 expression in general to identify other isoforms and a more sensitive test is needed to 
probe for any change of expression of additional SePP1 isoforms in this cell line, as it has been 
reported that immunoblot staining for the identification of SePP1 may not be the most reliable 
means of identification [75].  
SePP1 expression in HEK lysate is highly visible for HEK conditions with no ZIKV infection, 




the western blot (Figure 7, Panel B). HEK average expression of SePP1 is reported at 43,500 for 
the positive control, and that increases to 80,100 when the cell environment is supplemented with 
20nM sodium selenite. This increase in SePP1 expression from the control HEK lysate to HEK 
lysate with selenium supplementation is expected as several studies have reported an increase of 
selenoprotein expression with the addition of bioavailable selenium added to subject diets in 
environments were the subjects initially had a selenium deficient diet [77, 81-83]. Other studies 
with SePP1 knockout mice have shown that neurological symptoms like impaired motor 
coordination, audiogenic seizures, and brainstem neurode-generation can be avoided with 
appropriate levels of selenium added to the diet [6, 49, 84]. Going further, a 2004 study observed 
the progeny of SePP1 knockout mice, where the ability to synthesize specifically SePP1 had not 
only been diminished due to lack of dietary selenium, but completely negated. The SePP1 
knockout mice were bred, and the resulting pups were also SePP1-. The pups were further broken 
up into two experimental groups, one being allowed to nurse from a SePP1 knockout mother 
being fed dietary selenium and one nursing from SePP1 knockout mothers not being fed dietary 
selenium. The study found that when being allowed to nurse from the selenium supplemented 
mothers, the pups are able to circumvent the negative effects of the selenium deficiency caused 
by the inherited inability to express SePP1; these negative affects being neurodegeneration, 
seizures, and death [85]. Expanding these studies to the experiments described in this paper, 
sodium selenite, a bioavailable form of selenium, was added to non-ZIKV infected HEK cell 
culture medium for 3 full days and to ZIKV infected HEK cell culture medium 1 day after being 
ZIKV infected for 3 full days until the cells were harvested. With more selenium in the cellular 
environment, the cellular production of selenocysteine tRNA’s is expected to increase, meaning 




supplemented HEK cells, but that a slight rescue of SePP1 expression would be observed in the 
ZIKV infected selenium supplemented HEK cells; as is the observation in several studies 
looking at the effects of selenium supplementation on selenoprotein levels.  
SePP1 expression drops down to only 268 in ZIKV infected cells and increases to 416 once the 
ZIKV infected cells are supplemented with 20nM sodium selenite, however this slight 0.3% 
increase in SePP1 protein expression is not statistically significant or biologically relevant. In all 
experimental runs, SePP1 expression in HEK+ZIKV+Se experimental conditions as compared 
the SePP1 expression in HEK+ZIKV experimental conditions increased by an average of 197 
(Table A1, Appendix A).  
The lack of sodium selenite rescue of SePP1 expression in ZIKV infected cells is interesting 
especially when compared to the literature. An epidemiological study following the rate and 
severity hantaviral infection (RNA based family of viruses causing encephalitis that has shown 
to cause fatal acute neurological disease in mice) in mainland China has shown that people living 
in areas where the soil has deficient selenium levels have 6 times the likelihood of developing 
hantaviral related hemorrhagic fever with renal syndrome and a significant higher likelihood of 
mortality from the resulting condition [86]. The study saw that patients admitted to the hospital, 
once selenium supplemented, had increased levels of selenoprotein activity and plasma levels of 
selenium and alleviated symptoms [87]. Studies have indicated a high importance of TXNRD1 
and glutathione peroxidase to the cell in regard to viral infection response, and have shown that 
even with selenium supplementation, that other selenoproteins in humans like glutathione 
peroxidase were prioritized and those concentrations were optimized in the cell before SePP1 
levels were corrected upon viral infection, selenoprotein knockdown, or in cancer cells [58, 88]. 




recycling in the cell previously discussed, the conclusion could be drawn that other 
selenoproteins like TXNRD1 and glutathione peroxidase 1 were prioritized over SePP1 
expression. Selenium is a limited resource and the mechanism for selenoprotein translation is 
already inefficient. TXNRD1 and glutathione peroxidase have stronger literary references to 
being tied to anti-viral response than SePP1, so it would stand to reason that even with the 
addition of sodium selenite, that the synthesis of these proteins would be prioritized by the cell in 
















Figure 8: Western blot analysis of TXNRD1 expression in ZIKV infected HEK 293T cells. A. Western blot 
of TXNRD1 protein expression under several experimental conditions (with or without addition of 20 nM 
sodium selenite, either ZIKV+ or ZIKV−). Equal concentrations of protein were used per sample. Lanes are 
designated in the images. Results show:  A. Anti-TXNRD1-labeled protein bands across experimental 
conditions at the 55 kDa level, which corresponds to the predicted mass of TXNRD1. About a 90% decrease in 
TXNRD1 protein expression is seen in ZIKV-infected cells.   B. Quantitative expression of TXNRD1 expression 
in experimental conditions (Y axis shows fluorescence intensity units/1000). HEK TXNRD1 expression starts at 
46,500, decreases to 28,300 for HEK+Se, drops to 4,480 for HEK+ZIKV, and increases slightly to 6,030 for 
HEK+ZIKV+Se. Error bars are ± standard error of the mean, * indicates a p-value ≤ 0.05.   




An analogous western blot was performed with the same sample set probing for TXNRD1 
expression across the experimental conditions: HEK cells with 20 nM sodium selenite 
supplemented into the cell media, HEK cells infected with ZIKV for 96 hours, and HEK cells 
infected with ZIKV for 96 hours and supplemented with 20 nM selenium for 72 hours. Figure 8 
(Panel A) shows expression of TXNRD1 across all experimental conditions at the 55 kdal line 
which corresponds to the molecular weight of TXNRD1 [89]. TXNRD1 expression in HEK 
lysate is highly visible for HEK conditions with no ZIKV infection, compared to HEK 
conditions with ZIKV infection; where TXNRD1 expression can hardly be visualized on the 
western blot. Image analysis data shows HEK positive control non-infected and non-
supplemented TXNRD1 expression at 46,500 (Figure 8, Panel B). Surprisingly, this number 
decreases by 39.1% to 28,300 once sodium selenite is supplemented into the cell culture media 
(Table A2, Appendix A). Again, it is unlikely that this observation is a result of any cytotoxic 
effect of the sodium selenite, as the sample used to probe for TXNRD1 expression was the same 
sample used to probe for SePP1 expression. This indicates that something else has occurred. The 
majority of literature pertaining to TXNRD1 expression, as with SePP1 expression, shows that 
an increase of bioavailable selenium leads to an increase in TXNRD1 protein expression [81, 
90]. One theory as to why this phenomenon was not observed with this experimentation is in the 
cell lines used for the experiments. HEK293T cells are from an immortalized human fetal kidney 
cell line; one study looking at zebra-seabream TXNRD1 expression when exposed to dietary 
selenium showed similar results to the ones displayed in Figure 8 in the zebra-seabream kidney 
tissue samples [91]. The drop in TXNRD1 expression observed in zebra-seabream kidney cells 
when exposed to dietary selenium is similar in its quantity to the TXNRD1 drop witnessed in 




being a consistent and observable occurrence in TXNRD1 expression in kidney cell lines versus 
some other erroneous variable. Another study looking at the over expression of TXNRD1 in 
HEK293T cells found that the activity of TXNRD1 rather than the concentration of TXNRD1 is 
increased in these cell lines in the presence of environmental selenium supplementation, so while 
excess selenium has been supplemented into the HEK+Se experimental condition, it could only 
be affecting the efficiency of activity of TXNRD1 versus cellular concentration [92]. Providing 
additional insight to the slight decrease in TXNRD1 expression observed in the HEK+Se 
condition, several studies connect excess selenium with inhibitory effects on the TXNRD1 
system that are correlated with growth, migratory, and differentiation ability of the cell [93-95]. 
These factors rather than any erroneous variable in the experiment design lend explanation to the 
TXNRD1 expression level in the HEK+Se experimental condition. 
Similar to the observations presented concerning SePP1 expression in ZIKV infected cells, a 
dramatic decrease in TXNRD1 expression with ZIKV infection is seen. TXNRD1 expression in 
ZIKV infected cells drops to 4,480 which translates to a 90.4% decrease in TXNRD1 expression 
(Table A2, Appendix A). The observed decrease in TXNRD1 expression by 90.4% in ZIKV 
infected HEK cells strongly supports the hypothesis that ZIKV infection in the cell leads to a 
knockdown of TXNRD1 expression. The drop in TXNRD1 expression is significant when 
compared to the control, and while it was a large drop in protein expression, roughly 10% of 
TXNRD1 expression remained versus the near complete knockdown of SePP1 expression 
observed in ZIKV infected cells. In addition to the drop in TXNRD1 expression not being as 
severe, some positive effect on TXNRD1 expression in ZIKV infected cells with selenium 
supplementation was observed; which was not the case with SePP1 expression (Tables A1 and 




which translates to a 3.40% increase in expression (with a total decrease in overall TXNRD1 
expression being 86.8% from just HEK lysate) with sodium selenite supplemented into the cell 
culture media (Table A2, Appendix A). TXNRD1 selenium rescue in expression is minor but 
statistically significant, while any rescue observed with SePP1 expression is not. These 
observations regarding SePP1 and TXNRD1 expression in selenium supplemented ZIKV-
infected cells are interesting, especially when comparing them to the observations regarding 
SePP1 and TXNRD1 protein expression in the HEK+Se condition. For SePP1, there seemed to 
be no observable rescue of protein expression with sodium selenite supplemented to the media, 
despite there being more protein expression in non-infected cells with sodium selenite 
supplementation. This is the inverse of what was observed with TXNRD1 expression in non-
ZIKV infected vs ZIKV infected selenium supplemented condition. Despite there being an initial 
decline in TXNRD1 expression in the HEK+Se experimental condition, there is a notable 
increase from 4,480 in the HEK+ZIKV experimental condition to 6,080 in the HEK+ZIKV+Se 
experimental condition. While an 90.4% decrease in TXNRD1 expression is still substantial in 
the HEK+ZIKV experimental condition, it is not as large or as significant a drop in activity as 
compared to SePP1 expression in that same condition. This observation could be due to the cell 
prioritizing TXNRD1 and even glutathione peroxidase 1 expression over SePP1 expression as 
part of a cellular response to viral infection. Studies have also shown that when TXNRD1 
expression in the cell is knocked down, that those cells experience strongly enhanced production 
of glutathione, which also increases cell susceptibility to selenium [95, 96]. A 2009 study 
demonstrated that in the presence of glutathione and selenium, 90% of ZIKV viral replication 
was knocked down with an ED90 dose of 2.5 mM of selenium in human cells [97]. Drawing 




increase of TXNRD1 expression in the HEK+ZIKV+Se condition could be a combined result of 
TXNRD1 knockdown, being caused by ZIKV infection, triggering a cellular response to increase 
glutathione production. This theoretical increase in glutathione production would be occurring in 
presence of excess selenium in the HEK+ZIKV+Se experimental condition; this is in addition to 
the cell already being more sensitive to environmental selenium due to the TXNRD1 knockdown 
caused by ZIKV infection. All of these factors could lead to the diminishing ZIKV viral 
replication while prioritizing glutathione expression in the cell versus TXNRD1. This is 
supported by the RT-qPCR data concerning ZIKV RNA presence in the HEK+ZIKV+Se 
(Tables 2 and 3). Future experiments looking at the cellular production of glutathione and the 
expression of glutathione peroxidase in relation to TXNRD1 expression in ZIKV infected cells is 
needed to further explore these connections. 
Epidemiological data has shown that individuals with HIV-1 who are selenium deficient have a 
higher likelihood of the condition progressing to AIDS, indicating that there is a clear connection 
between selenium, selenoprotein expression specifically in regard to TXNRD1, and viral 
pathogenesis progression in the host [98]. Research has shown that TXNRD1 expression is up to 
7 times higher in a developing fetus than in an adult, specifically in fetal multipotential neuronal 
progenitor cells, indicating that TXNRD1 expression is important to the developing and 
differentiating cells [63]. In addition, literature cites transmembrane protein AXL as an entry 
method into the cell by ZIKV, which is expressed in these cells [99, 100]. Studies have not only 
confirmed that these cells can be infected by ZIKV virus specifically, but additionally have 
shown that human fetal brain derived multipotential central nervous system progenitor cells, 
when infected with virus, aren’t able to differentiate to astrocytes, dendritic cells or glial cells 




brain are additive to studies showing that when cells that do not express TXNRD1 or experience 
a significant decrease in TXNRD1 activity, they undergo an increased rate of apoptosis [13, 101-
103]. Connecting these studies to the fact that cells not expressing TXNRD1 undergo apoptosis 
and the data this paper has shown demonstrating an 90.4% decrease in TXNRD1 expression in 
ZIKV infected cells, it can be extrapolated that ZIKV induced TXNRD1 knockdown in the fetus 
leads to apoptosis in fetal multipotential NPCs; this could be an additional compounding factor 
in the onset of microcephaly in ZIKV+neonates. Selenium deficiencies have already been shown 
to lead to increased development of dangerous secondary conditions the virus can cause in the 
inflected individual [104-107]. This suggests that addition of dietary selenium could aid in the 
circumvention of the onset of harmful secondary conditions. The experimentation presented here 
does not align fully with the literature however, with just a 3.40% rescue of TXNRD1 expression 
in ZIKV infected cells with the introduction of environmental selenium in the cell culture media. 
A limitation of the study was that selenium supplementation of the cell culture media was only 
tested at a 20nM concentration. This was chosen for this line of experiments based on other 
studies in the lab group involving the optimization of viral stop codon readthrough in the 
presence of dietary selenium [2]. If SePP1 expression is knocked down in the ZIKV infected 
cells, especially the placental cells, of a pregnant individual, then little to no selenium is being 
transported to the developing fetus. Not only is this a concern for developing neurons that need 
the micronutrient, but it is a concern for TXNRD1 expression in the fetal developing NPCs as 
well. Rescue of TXNRD1 expression in ZIKV infected individuals by dietary selenium could 
decrease apoptosis in multipotential fetal NPCs, thus reducing the risk of microcephaly onset. 
The western blot data in both Figure 7 and Figure 8 show ZIKV dramatically knocks down the 




the developing fetus, especially in terms of the developing neuronal cells, could be the perfect 
storm that leads to ZIKV congenital microcephaly. The non-effect selenium supplementation had 
on the protein expression of SePP1 and TXNRD1 despite extensive literature supporting the 
opposite conclusion is indicative of the need for future studies to look further into selenium 
supplementation, protein expression rescue, and a decrease in the onset of secondary conditions 
brought on by RNA based viruses like the cases observed with ZIKV and microcephaly.  
2.4b RT-qPCR data 
Table 2: Rt-qPCR results of amplified RNA species from RNA purified from experimental 





















SePP1 RNA levels      
HEK 20.58 ±3.3    
HEK+ZIKV 17.99 ±0.53 0.13   
HEK+Se 19.90 ±0.90 0.72   
HEK+ZIKV+Se 19.14 ±0.83 0.43 0.26 0.059 
TXNRD1 RNA levels      
HEK 19.80 ±2.2    
HEK+ZIKV 20.31 ±4.0 0.83   
HEK+Se 19.23 ±1.8 0.70   
HEK+ZIKV+Se 16.81 ±2.121 0.097 0.13 0.17 
ZIKV RNA levels      
HEK 28.12 ±1.1    
HEK+ZIKV 25.59 ±2.9 0.0055*   
HEK+Se 27.70 ±0.43 0.79   
HEK+ZIKV+Se 26.83 ±2.1 0.32 0.64 0.29 
Primers designed for the amplification of SePP1 mRNA, TR1 mRNA and ZIKV RNA were used to amplify and 
determine original RNA levels of each amplicon for each experimental condition (Table 1). In columns 5 and 6, 
Ct values for the HEK+Se condition were compared against Ct values for the HEK+ZIKV+Se contition to 
determine if a statistically significant difference in the average Ct values occurred between non-ZIKV infected 
and ZIKV-infected HEK293T selenium supplemented cells. In columns 5 and 6, Ct values for the HEK+ZIKV 
condition were compared against Ct values for the HEK+ZIKV+Se condition to determine if a statistically 
significant difference in the average Ct values occurred between non-selenium supplemented ZIKV-infected 
and selenium supplemented ZIKV-infected HEK293T cells. P-values were generated using a Two sampled, 2-
tailed t-Test assuming equal variance. Ct values for each condition for each experimental run are in Appendix 




Rt-qPCR data was collected on total RNA collected from all experimental samples for levels of 
ZIKV RNA, SePP1 mRNA and TXNRD1 mRNA. All experimental samples from which the 
data obtained were identical, with only different primers being used depending on what RNA 
amplicon was being targeted. In Table 2, the average Ct values of all amplicons of the different 
RNA targets for the rt-qPCR results from the purified RNA. All data in table was calculated 
from quadruplicate data points for each condition for each amplicon. The Ct value is inversely 
related to how much starting material (target RNA meaning either SePP1 mRNA, TXNRD1 
mRNA or ZIKV RNA for these experiments) was in the original RNA sample before 
amplification. Meaning the lower the average Ct value, the more of that target RNA was in the 
original sample. In Table 3, relative quantification was analyzed by comparing a control Ct 
value (non-infected, non-selenium supplemented HEK lysate, Ctcontrol) to experimental Ct values 
(experimental conditions involving ZIKV infection, selenium supplementation, or both; 
Ctexperimental) with the formula 2
∆Ct, where ∆Ct was defined as Ctcontrol-Ctexperimental. When 
purifying the RNA from all samples, a cell count was performed on the cell pellets so that an 
equal number of cells from each sample would undergo RNA extraction. From this, equal 
amounts of total RNA starting material were added to the PCR wells to eliminate variables. 
ZIKV RNA was targeted as a means to show proof of viral infection and propagation in the 
experimental conditions and to test possible effects selenium supplementation had on ZIKV 
these variables in HEK 293T cells. Both mRNA for SePP1 and TXNRD1 expression were 
targeted to assess the effect ZIKV infection has SePP1 and TXNRD1 expression at the mRNA 
level and if selenium supplementation either negated or exasperated these effects.  
 Looking at the data for SePP1 mRNA amplification, the Ct average for HEK lysate only with no 




condition with selenium supplementation had a slightly lower average Ct value of 19.90 (Table 
2) which translates to a 1.6 fold increase in SePP1 mRNA originally in the RNA samples from 
the HEK+Se experimental condition as compared to HEK lysate only. This falls in line with 
literature indicating that more selenium in the environment leads to an increase in selenoprotein 
expression as sodium selenite is a bioavailable form of selenium. As discussed, selenoproteins 
are formed with the translational insertion of selenocysteines through UGA stop codon 
readthrough. This amino acid can only be synthesized with materials coming from dietary 
sources of bioavailable selenium like sodium selenite, and an increase in the expression of these 
proteins is associated with an increase in dietary selenium, which by relations would indicate an 
increase in SePP1 mRNA in the cell as well. The predicted increase of selenoprotein expression 
was also seen at the protein level of SePP1 (Figure 7), with an increased expression of 84.1% 
(Table A1, Appendix A). The RT-qPCR data and the protein expression data match up and both 
support an increase in SePP1 expression at both the mRNA and protein level for the HEK+Se 











Table 3: Relative analysis of initial RNA species present (SePP1 mRNA, TR1 mRNA and ZIKV 
RNA) in experimental samples versus control samples. 
Experimental 
sample 
*2∆Ct where Ctcontrol 
average=CtHEK average 
 *2∆Ct where Ctcontrol 
average≠CtHEK average 
SePP1 RNA levels    









TXNRD1 RNA levels    








ZIKV RNA levels    









Surprisingly, the Ct average value for SePP1 mRNA from the HEK+ZIKV experimental 
condition was even less when compared to SePP1 mRNA levels from both the HEK lysate only 
condition and HEK+Se experimental condition, coming in at 17.99. This translates to 6.0 fold 
increase in the amount of SePP1 mRNA in the original sample from this condition as compared 
Fold differences in RNA species levels between non-infected/non-selenium supplemented HEK293T control 
samples and experimental ZIKV infected/selenium supplemented samples was calculated using the formula 2∆Ct, 
where ∆Ct is defined as Ctcontrol-Ctexperimental. In column 2, Ctcontrol is defined as the Ct average for RNA samples 
from the HEK only condition and Ctexperimental is defined as the Ct average for any RNA samples from 
experimental conditions HEK+ZIKV, HEK+Se and HEK+ZIKV+Se. In column 5, Ctcontrol is defined as either the 
Cr average for HEK+Se or HEK+ZIKV as indicated in column 4; and Ctexperimentalis defined as the Ct average for 
HEK+ZIKV+Se. All Ct values used in formula calculations were derived from the calculated averages of all the 
Ct values for the relevant RNA species in each experimental condition. P-values derived in columns 3 and 6 were 





to the HEK lysate only condition and a 4.4 fold increase when compared to the HEK+SE 
condition; indicating that with ZIKV infection, HEK cells produce even more SePP1 mRNA 
than both native HEK cells and HEK cells with sodium selenite supplementation. Despite the 
99.4% knockdown of SePP1 protein expression that these experiments have shown to happen in 
ZIKV infected cells, more SePP1 mRNA is observed in the HEK+ZIKV experimental condition. 
This could support that the proposed RNA antisense interaction between SePP1 mRNA and 
ZIKV RNA is occurring, that the interaction either does not last long enough to trigger cell 
immune response to a double stranded RNA species in the scope of these experiments, or that 
since the nucleotide length of the interaction is predicted to be relatively short, that the cell could 
be mistaking it as RNA secondary structure, thus not targeting it for degradation anyway. This 
makes sense, because if the proposed antisense interaction occurred in such a way as to alert the 
cell of a double stranded RNA species, it would trigger an anti-viral cell immune response and 
thus would not be advantageous to the propagation of ZIKV RNA. It has been explained that the 
proposed antisense region between ZIKV RNA and SePP1 mRNA is highly conserved, so it 
would not make sense at an evolutionary level for the virus to have a conserved sequence in its 
genome that leads to host cell degradation of its RNA. In addition, evidence has been shown that 
not only can flaviridae viruses like ZIKV replicate in the nucleus of the infected cell, but that the 
UGA decoding complex for selenoprotein mRNAs, specifically in the case of SePP1 mRNA, 
also can occur within the cell nucleus. It is postulated that this is how SePP1 mRNA avoids non-
sense mediated RNA decay in the cell [80]. This provides further evidence that the hypothesized 
interaction between SePP1 mRNA and ZIKV RNA is possible in terms of cellular localization of 
both RNA species, energetic favorability, and that temporary RNA secondary structures resulting 




The increase in SePP1 mRNA with ZIKV infection could be due to a multitude of factors. A 
2019 study correlates to an increase in SePP1 mRNA translation in cell with Hepatitis C 
infection and shows that SePP1 mRNA binds to RIG-1; an important protein involved in cellular 
immune response to viral infection. The study concluded that this interaction between RIG-1 and 
SePP1 mRNA caused a decrease in cellular immune response to Hepatitis C infection, thus 
increasing the proliferation rate of the virus [108]. This relationship between SePP1 mRNA 
induction, RIG-1 binding, and decline in cellular response to viral infection is interesting because 
ZIKV is part of the flaviridae viral family. This family of viruses incorporate a similar strategy 
by using subgenomic flaviviral RNA truncated from the 3’UTR region of their genomes to 
interact with RIG-1 to decrease cellular immune response [35, 38, 66, 109]. Interestingly, several 
reviews on the biosynthesis and regulation of selenoenzymes in mammals indicate that the 
translational mechanism of the ribosome reading through the UGA stop codon when translating a 
selenoprotein mRNA is the limiting factor in the expression of these class of proteins, and due to 
all that is involved in this translational insertion complex, a UGA readthrough as a 
selenocysteine codon is an inefficient phenomena [110]. Anything interfering with this already 
tendentious process would dramatically decrease the amount of selenoproteins produced by host 
cells regardless of how many times the interaction occurred, due to how involved the mechanism 
of selenoprotein expression is already. This could explain why an increase in SePP1 mRNA is 
seen in ZIKV infected cells. Even if the proposed interaction only happened briefly in the cell, it 
could be enough to pause the ribosome so that the SePP1 mRNA would get dislodged, resulting 
in it not being translated and leading to excess SePP1 mRNA in the cytosol whose translation 
was interrupted. However, if this one to be the case, an increase in the expression of truncated 




selenocysteines. As discussed with the observations regarding the SePP1 western blot, no such 
truncated proteins were observed. Viruses are known to increase reactive oxidative species 
(ROS) in the cells they infect, and selenoproteins are part of an antioxidant group of enzymes 
that helps mitigate these affects. This increase in ROS caused by viral infections like ZIKV lead 
to an imbalance between the normal levels of cellular ROS and the cellular antioxidant enzymes, 
triggering the cellular antioxidant defense system [50]. As SePP1 protein expression gets 
knocked down (Figure 7), the cell could prioritize SePP1 translation in an attempt to restore 
selenohomeostatsis, which could an additional reason why an increase of SePP1 mRNA is 
observed in the HEK+ZIKV experimental condition (Tables 2 and 3) [3, 77]. 
The average Ct value for SePP1 mRNA is most interesting in the HEK+ZIKV+Se condition. 
Here, the Ct value has increased from the HEK+ZIKV condition from 17.99 to 19.14; meaning 
that there is less SePP1 mRNA in the ZIKV infected samples with selenium supplementation 
samples than in the samples from the ZIKV infected only condition. There is still a 2.7 fold 
increase in SePP1 mRNA levels from the HEK only condition, but considering the large fold 
increase in SePP1 mRNA observed in the HEK+ZIKV condition and the 1.6 fold increase in 
SePP1 mRNA in the HEK+Se condition, a higher fold difference in the HEK+ZIKV+Se 
condition was expected from the HEK only condition. With what is known about selenium 
supplementation and selenoprotein expression, the prediction was that SePP1 mRNA levels in 
the HEK+ZIKV+Se condition would be higher than those in the HEK+ZIKV condition [77]. 
However, the opposite is observed, with the SePP1 mRNA levels being 0.45 fold less in the 
HEK+ZIKV+Se condition than the SePP1 mRNA levels in the HEK+ZIKV condition. This is a 
good indicator that the proposed antisense interaction between ZIKV RNA and SePP1 mRNA is 




because while a significant rescue of SePP1 expression was not observed with the western blot 
data (Table A1, Appendix A), a decrease of SePP1 mRNA in the same experimental condition 
is observed. Since there is less SePP1 mRNA in the HEK+ZIKV+Se condition and slightly more 
SePP1 protein expression in the same condition, it could indicate that adding the extra selenium 
to ZIKV infected cells may not be encouraging more SePP1 protein expression at the mRNA 
level but rather making it easier for the SePP1 mRNA already transcribed to circumvent the 
proposed antisense interaction with the ZIKV RNA in order to be successfully translated.  
The Ct average for the HEK lysate regarding TXNRD1 mRNA levels is 19.80, with the Ct 
average for the HEK+Se condition coming just slightly lower at 19.23, translating to a 1.5 fold 
increase in TXNRD1 mRNA levels from HEK lysate alone. This difference in TXNRD1 mRNA 
between the HEK condition and the HEK+Se condition is relatively the same one observed with 
the SePP1 mRNA levels between these conditions, with the difference between Ct values being 
0.68 difference for SePP1 mRNA and 0.57 difference for TXNRD1 mRNA. This again 
coordinates well with literature that supports an increase in expression of selenoproteins in the 
presence of environmental selenium. What is interesting is that the average Ct value for the 
HEK+Se condition was lower than the positive control for TXNRD1 mRNA, indicates a higher 
level of TXNRD1 mRNA in the RNA sample from this condition, but the protein expression 
level of TXNRD1 for the HEK+Se experimental condition was 39.1% lower than that of the 
HEK alone condition (Table A2, Appendix A). So, the increase in TXNRD1 mRNA levels in 
the HEK+Se condition did not translate to an increase in TXNRD1 protein expression. Another 
lab studies the effects of selenium and TXNRD1 expression using a stability generated 
HEK293T cell line that overexpresses TXNRD1. They have reported that selenium 




translating into an increased protein amount [92]. This could aid in the explanation as to why 
there is an observed increase in TXNRD1 mRNA in the HEK+Se condition while a decrease in 
TXNRD1 protein expression. Regarding TXNRD1’s role in cell homeostasis as well, it is widely 
reported that TXNRD1 overexpression in HEK 293T cells leads to the cells not being able to 
migrate or differentiate properly [90, 93, 96]. Based on this literary evidence, a possible 
conclusion regarding the increase in TXNRD1 mRNA in the HEK+Se condition and the 
concurrent decrease in TXNRD1 expression is that by the environmental selenium increasing the 
amount of TXNRD1 mRNA, it could have triggered some cell response calling for degradation 
of TXNRD1 protein.  
Even more of interest, when looking at the TXNRD1 RT-qPCR data is when it is in comparison 
with the SePP1 RT-qPCR data. The average Ct value increases in the HEK+ZIKV experimental 
condition for TXNRD1 mRNA from 19.80 to 20.31, translating to a 0.70 fold decrease from 
HEK lysate. This means that HEK cells infected with ZIKV on average had less TXNRD1 
mRNA than non-ZIKV infected HEK cells, which is a very large difference from the 6.0 fold 
increase of SePP1 mRNA in ZIKV infected cells that was previously observed. This is in 
conjunction with a smaller decrease in the knockdown of TXNRD1 in ZIKV infected cells. With 
SePP1, a 99.4% decrease is seen in protein expression along with the 6.0 fold SePP1 mRNA 
increase in ZIKV infected cells. With TXNRD1, only 90.4% of protein expression was knocked 
down and a 0.70 fold decrease is seen in TXNRD1 mRNA levels (although the differences in 
mRNA levels are not statistically significant) (Table A4, Appendix A). Applying the same logic 
used to explain the slight decrease in SePP1 mRNA and a slight increase in SePP1 protein was 
observed in the HEK+ZIKV+Se condition, the 0.70 fold decrease in TXNRD1 mRNA levels 




cells than SePP1 mRNA was. As previously stated, the literature demonstrates that cellular levels 
of TXNRD1 and glutathione peroxidase 1 are prioritized over SePP1 levels in the presence of 
virus. TXNRD1 and glutathione peroxidase 1 are also expressed at a higher rate than SePP1 is 
when the cell is undergoing stress [88]. Stated in the introduction, the ZIKV RNA:SePP1 mRNA 
antisense interaction spans an intron/exon junction, indicating that this interaction could be 
happening between ZIKV RNA and SePP1 pre-mRNA.  Additionally, there is substantial 
evidence that points to the SePP1 mRNA:ZIKV RNA antisense interaction occurring within the 
cell’s nucleus due to characterized traits of both flaviridae replication and SePP1 mRNA 
translation; this means that this antisense interaction could in theory occur with both mature and 
pre SePP1 mRNA species and within the nucleus. The predicted antisense interaction region 
between ZIKV RNA and TXNRD1 mRNA occurs on an intron, meaning that the chances of this 
interaction occurring are already less than with SePP1 mRNA species because ZIKV RNA only 
has the possibility of interaction with TXNRD1 pre-mRNA. In addition, not only is the predicted 
interaction shorter with ZIKV RNA and TXNRD1 mRNA than it is with SePP1 mRNA, but it is 
also less stable. Putting this together, not only does ZIKV have a shorter window of opportunity 
to interact with TXNRD1 mRNA, but that interaction is less stable and more likely to be targeted 
for degradation by native rnases. This could be why there is a less dramatic decrease of 
TXNRD1 protein expression in ZIKV infected HEK293T cells but also why there is less 
TXNRD1 mRNA in this condition as well. 
However, that theory comes into question when the average Ct values for TXNRD1 mRNA in 
the HEK+ZIKV+Se experimental condition are considered. The average Ct for TXNRD1 mRNA 
in the RNA from the HEK+ZIKV+Se experimental condition was 16.81, which is 8.0 folds 




levels in the HEK+ZIKV condition versus the HEK+ZIKV+Se condition, while the Ct average 
was markedly lower for the former (indicating more TXNRD1 mRNA in the RNA purified from 
the HEK+ZIKV+Se condition versus the HEK+ZIKV condition), the difference was not 
statistically significant when compared against the other, despite the Ct average difference 
actually being larger than the difference between the Ct average for the positive control and the 
HEK+ZIKV+Se condition. This increase in TXNRD1 mRNA in the HEK+ZIKV+Se condition 
could explain the 3.40% TXNRD1 increase in protein expression observed in the same 
experimental condition (Figure 8). 
As expected, non-infected and non-selenium supplemented HEK lysate had an exceedingly high 
average Ct value for the ZIKV RNA amplicon target at 28.12 (Table 2). This indicates that it 
took over 28 of the 40 PCR cycles to get enough amplification of the ZIKV RNA target to get 
enough fluorescence to be visualized above the baseline. These results show that there was little 
to no starting material for amplification of this target to be successful in this sample and correlate 
to other studies looking at ZIKV Ct values and their negative controls [111]. A similar trend is 
seen is the non-infected HEK + Se lysate sample, where a 0.42 decrease in the Ct average for 
ZIKV amplicons was observed. This indicates a minimal increase in the amplification of 
theoretical ZIKV RNA as represented in Table 2 where that slight decrease in Ct value translates 
to a 1.4 fold increase in theoretical ZIKV RNA being originally present in the sample. This data 
was not determined to be statistically significant, and any amplification observed in these two 
experimental conditions (HEK and HEK+Se) at this stage is likely due to non-specific binding of 
primers to the starting material versus any amplification of the ZIKV RNA target, as is reported 
with samples containing less than 105 RNA copies/mL; as the sensitivity of the RT-PCR assay is 




deviation for the HEK+Se condition is considerably higher than the other standard deviations for 
the ZIKV amplicon data set; leading credence to the argument that any amplification is likely 
due to non-specific binding. ZIKV-infected HEK lysate shows a statistically significant decrease 
in Ct average value from the non-infected condition (Table 2) by 2.53 translating into a fold 
increase of 5.8 (Table 3) and keeping in line with average Ct values of previous ZIKV 
RNA/viral load studies utilizing RT-qPCR method. A Ct average of 25.60±1.138 is reported 
from the RT-qPCR data from serum containing 50,000 PFU/mL of ZIKV, and the observed Ct 
average value for the HEK+ZIKV condition is 25.59±2.9 indicating positive ZIKV infection 
with viral replication falling in line with the literature [111].  
Observing the HEK+ZIKV+Se data sets, it’s indicated that selenium added to the ZIKV infected 
HEK cells increases the Ct average of ZIKV amplicons by 1.24 translating to only a 2.5 fold 
increase in ZIKV RNA present in the sample as compared to the non-infected, non-selenium 
supplemented condition. This is 3.4 fold decrease in difference from the control when compared 
to the HEK+ZIKV condition, meaning that selenium supplementation overall decreased ZIKV 
viral RNA originally present in the sample. When directly comparing the average Ct values 
between the HEK+ZIKV and the HEK+ZIKV+Se experimental conditions, the difference was 
not found to be statistically significant (Table 2). When comparing the fold difference in these 
two conditions by treating HEK+ZIKV as the Ctcontrol and the HEK+ZIKV+Se condition as the 
Ctexperimental, a 0.42 fold decrease in ZIKV RNA present from the HEK+ZIKV condition to the 
HEK+ZIKV+Se condition is observed. Multiple studies have listed inhibitory effects selenium 
supplementation has on various cellular stressors including viral infection and proliferation, so 
decrease in ZIKV RNA levels in ZIKV infected cells supplemented with selenium was the 




indicating that while selenium supplementation did reduce ZIKV RNA levels, it had no 
significant restorative effect for the selenobiochemisty of the cell. The experiments described in 
this paper did not use any free form amino acid supplementation in conjunction with the sodium 
selenite, other than the 5% glutamate added to the cell culture media, and no multivitamin or 
other supplements were added to the cell culture media. Studies citing a circumvention of 
negative viral affects and pathogenicity reported greater results when these variables were used 
concurrently with selenium supplementation [106, 114, 115]. Additionally, the dosage of sodium 
selenite used on the ZIKV infected HEK cells was significantly larger in the cited studies than in 
the one outlined in this paper, which could also explain why little protein rescue was seen despite 
seeing large differences selenium had on ZIKV RNA, SePP1 mRNA and TXNRD1 mRNA in 
ZIKV infected HEK293T cells. If selenium supplementation decreases the amount of viral RNA 
present, then the proposed antisense mediated knockdown of SePP1 and TXNRD1 protein 
expression would decrease, which could explain the slight increase in those levels of protein 
expression in the HEK+ZIKV+Se condition. In animal models, viruses have a documented 
reaction that can alter their genomes due to oxidative stress in selenium deficient or 
selenoprotein deficient cells. This creates a more pathogenic strain of the virus that is more 
virulent that the original infectant. It has also been reported that in glutathione peroxidase 
knockdown mice infected with Human Enterovirus, the viral genomic RNA change as compared 
to control mice undergoes mutations to become a more virulent strain [50, 116]. These 
observations reported by other researchers could be why a decrease in ZIKV RNA is observed in 
the HEK+ZIKV+Se condition, but no real protein rescue of TXNRD1 or SePP1 is witnessed. 
The ZIKV viral RNA could be reacting to the increased ROS in the cell and the knockdown of 





We have displayed compelling evidence that ZIKV viral RNA has an affinity to interact with 
host selenoprotein mRNA coding for the expression of SePP1 and TXNRD1; and we have 
shown that this interaction is possible on the molecular level through a gel-shift assay using 
matching oligos to the predicted regions of interactions between the host cell selenoprotein 
mRNAs and the ZIKV viral RNA. The data put forward through these experiments clearly shows 
that knockdown of host cell selenoprotein expression of SePP1 and TXNRD1 occurs in ZIKV 
infected cells, with SePP1 expression dropping 99.4% and TXNRD1 expression dropping 
90.4%. This effect of ZIKV infection seems to be unaffected by supplementation of selenium to 
the environment, with rescue of host selenoprotein expression not being at a level where it is 
biologically relevant. RT-qPCR data shows that SePP1 mRNA increases in the presence of 
ZIKV infection by about 6 fold, despite there being almost no noticeable protein expression. This 
adds further validation to the argument that ZIKV RNA is interfering with SePP1 mRNA. 
Addition of selenium to ZIKV infected cells affects TXNRD1 mRNA expression significantly by 
an increase of 8.0 fold. ZIKV RNA also decreases by almost half a fold. Given the cellular 
functions of SePP1 and TXNRD1, and the documented effects selenoprotein knockdown or 
selenium deficiency have on neuronal conditions/neuronal development, we have provided a 
case for the connection of ZIKV infection, selenoprotein knockdown, and the onset of 
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3.1 Abstract 
The HIV-1 nef gene terminates in a 3’-UGA stop codon, which is highly conserved in the main 
group of HIV-1 subtypes, along with a downstream potential coding region that could extend the 
nef protein by 33 amino acids, if readthrough of the stop codon occurs. Antisense tethering 
interactions (ATIs) between a viral mRNA and a host selenoprotein mRNA are a potential viral 
strategy for the capture of a host selenocysteine insertion sequence (SECIS) element (Taylor et 
al, 2016) [2]. This mRNA hijacking mechanism could enable the expression of virally encoded 
selenoprotein modules, via translation of in-frame UGA stop codons as selenocysteine (SeC). 
Here we show that readthrough of the 3’-terminal UGA codon of nef occurs during translation of 





image analysis and flow cytometry of HEK 293 cells, transfected with engineered GFP reporter 
gene plasmid constructs, in which GFP can only be expressed by translational recoding of the 
UGA codon. SiRNA knockdown of thioredoxin reductase 1 (TXNRD1) mRNA resulted in a 
67% decrease in GFP expression, presumably due to reduced availability of the components 
involved in selenocysteine incorporation for the stop codon readthrough, thus supporting the 
proposed ATI. Addition of 20 nM sodium selenite to the media significantly enhanced stop 
codon readthrough in the pNefATI1 plasmid construct, by >100%, supporting the hypothesis that 
selenium is involved in the UGA readthrough mechanism. 
 
3.2 Introduction 
Our group has previously proposed the possibility of viral RNA/host mRNA antisense 
interactions as a gain-of-function strategy for viruses, via the tethering of a host mRNA 
containing functional structural or sequence elements [2]. In that study, we focused on two viral 
genes, the nucleoprotein (NP) of the highly pathogenic Ebola Zaire strain (EBOV) and the HIV-
1 nef gene, both of which terminate in highly conserved UGA stop codons, and both of which 
have, in close proximity to the UGA codon, extensive regions of antisense complementarity to 
the mRNA of an isoform of the mammalian selenoprotein thioredoxin reductase (TR3 in the case 
of the EBOV NP gene, and TXNRD1 in the case of HIV-1 nef). We proposed that these regions 
could provide the basis for “antisense tethering interactions” (ATI), and that in both cases the 
functional element being targeted by viral capture is the selenocysteine insertion sequence 
(SECIS) element located in the 3’-UTR of all human TR mRNAs [117]. This structural element 
is essential for translational recoding of in-frame UGA stop codons as selenocysteine (Sec), an 




unlikely to be a coincidence that the two genes in question, from very different RNA viruses, 
should both show evidence of antisense targeting of a human selenoprotein mRNA, that it is a 
TR isoform in both cases, in regions of the viral genome that prove to overlap or be within a few 
hundred bases on either side of a highly conserved in-frame UGA codon, recoding of which as 
Sec would lead to an extended selenoprotein isoform of the respective proteins (NP and nef), the 
sequence features of which are also conserved, even past the UGA stop codon. 
In mammalian TR enzymes, the Sec residue encoded by the UGA is geminal to a Cys residue at 
the C-terminal end of the protein, the Cys-Sec pair forming the C-terminal redox center of TR 
enzymes [117]. As we have pointed out previously, this is strikingly similar to the situation in the 
HIV- nef gene, which has a conserved C terminal Cys residue, followed immediately by the 
UGA stop codon, thus potentially forming a TR-like Cys-Sec redox pair if the UGA codon could 
be translated as Sec [119].  
Selenoproteins encoded in the genomes of bacteria, eukaryotes and archaea all encode Sec using 
the UGA codon, which otherwise, and far more commonly, serves as a stop codon [4]. To 
incorporate SeC into polypeptides, these organisms all use variants of a complex co-translational 
mechanism, a key feature of which is the involvement of a characteristic RNA stem-loop 
structure. In the mammalian system, this structure is the SECIS element, and is usually located in 
the 3’ untranslated region (3’ UTR) of the selenoprotein mRNA. Various protein factors, 
including SECIS binding protein2 (SBP2) and a special elongation factor, EFSec, work in 
conjunction with the SECIS element to bind tRNASec at the ribosome, suppress the termination 
factor, and thereby enable Sec incorporation at the UGA codon, preventing it from acting as a 




Given the universality of UGA codon use for Sec, it should not be surprising that viruses might 
also exploit this mechanism and benefit by the ability to synthesize alternate isoforms of certain 
viral proteins, e.g., by extending a protein via readthrough of a stop codon. The latter is actually 
a general strategy of some viruses, and recoding of UGA as Sec is only one special case of 
readthrough suppression, for which there are diverse mechanisms that can result in conventional 
amino acids being incorporated at any of the 3 stop codons, depending on the context. For 
example, murine leukemia virus (MLV) can only express its pol gene via translational 
readthrough involving the insertion of a glutamine at the position of a UAG stop codon that 
separates the gag and pol reading frames, an event that occurs at low but adequate efficiency 
(5%) [120]. This has evolved to give an appropriate 20:1 molar ratio in the quantity of gag 
structural proteins vs. the enzymes encoded in the pol gene.   
In addition to a potential selenoprotein isoform of nef associated with its 3’-UGA codon, based 
largely on computational analyses of the genomic structure of HIV-1, we have also previously 
identified several regions overlapping known HIV genes that potentially encode selenoprotein 
modules expressed by ribosomal frameshifting, including one that is a homologue of glutathione 
peroxidase (GPx) [5], and one with similarities to the transcription factor NF-κB, the primary 
cellular on/off switch for HIV [119, 121]. The HIV-1 GPx was cloned and expressed using a 
human SECIS element, and was found to encode functional GPx activity [5], and to protect 
transfected cells against oxidant-induced apoptosis [41]. 
However, neither we nor others were ever able to identify a functional SECIS element encoded 
by an RNA virus, which engendered considerable skepticism in regard to our findings, e.g. 
regarding the HIV-1 encoded GPx. The missing piece of the puzzle was finally provided by our 




that a virus would not need its own SECIS element if it could hijack one from the host, via the 
mRNA tethering mechanism outlined above. Since SECIS elements have the ability to function 
even when carried by a separate mRNA [3], it is highly probable that the presence of a SECIS in 
a tethered mRNA could also serve to decode certain in-frame UGA codons as Sec on the 
tethering viral RNA, particularly if this interaction was the result of a coevolutionary process and 
structural and mechanistic features had been optimized by evolutionary selection.  
Our preliminary support for this hypothesis in the case of the Ebola NP and HIV-1 nef genes was 
via a combination of computational analyses and confirmation of the antisense interactions at the 
DNA level, via gel shift assay of the specific fragments that were predicted to be involved in the 
core antisense interaction (what we called the ATI1 region), shown as interacting RNA 
secondary structures in Fig. 1 of Taylor et al [2]. The aim of the current study was to assess in 
vitro the predicted outcome of that interaction in the case of the nef gene, i.e., the potential for 
formation of a C-terminal extended isoform of nef, and to seek evidence of a role for TXNRD1 
mRNA in the efficiency of that readthrough. 
To that end, we designed three nef expression constructs based on a GFP expression vector that 
included the complete nef coding region inserted upstream of GFP. In between the nef and GFP 
coding regions were either one or both of the predicted antisense regions: ATI1, spanning the nef 
3’-UGA codon (pNefATI1 construct), and ATI2, which is further downstream in the 3’ end of 
the viral RNA (pNefATI2 construct, which contained both the ATI1 and ATI2 regions). These 
plasmids were designed so that in the “wild-type” pNefATI1 and pNefATI2 constructs, 
readthrough translation or bypassing of the nef 3’-UGA would enable translation of the 
downstream in-frame GFP domain. The third plasmid (pNefATIstop) was similar to pNefATI2, 




and GFP regions, to serve as a negative control by making GFP expression impossible even if 
UGA readthrough had occurred. 
In brief, the results reported here exploit that set of nef ATI constructs, along with anti-TXNRD1 
siRNA and appropriate control siRNAs, to demonstrate that readthrough of the nef 3’-UGA stop 
codon occurs with significant efficiency (~19%), is selenium-dependent, being more than 
doubled by the addition of 20 nM sodium selenite to cell culture media, and is significantly 
reduced, by about 67%, in the presence of an anti-TXNRD1 siRNA. These results 
unambiguously confirm the existence of an extended isoform of nef formed by translational stop 
codon readthrough and are consistent with the hypothesis that TXNRD1 may play a role in the 











Figure 9: Proposed mechanism of Sec incorporation into viral proteins via hijacking of a SECIS 
element from a tethered host selenoprotein mRNA. (Reproduced from Fig. 3 of Taylor et al, 2016 
[2]). Both panels show schematic ribosomes with two bound tRNAs, one carrying the Sec, the other a 
growing peptide chain shown as colored circles. The upper panel shows the established role of the 
SECIS element in the 3’-UTR region in the mechanism of insertion of Sec during mammalian 
selenoprotein biosynthesis [3, 4]. The panel below shows how the HIV-1 mRNA could hijack the host 
SECIS element via antisense tethering interactions (ATI) to decode UGA to synthesize viral 
selenoproteins such as the HIV-1 encoded GPx [5]. ATI-1 is a predicted interaction spanning the highly 
conserved 3’ UGA codon of the nef gene. ATI-2 is a second shorter antisense region consisting of 13 




3.3 Materials and methods 




investigate the potential read-through of the UGA stop codon at the end of HIV-1 nef a set of 
three plasmid vectors was constructed, each containing a green fluorescent protein (GFP) 
reporter gene downstream of the complete HIV-1 nef coding region, including most of the 3’-
LTR. The nef gene and LTR were obtained by PCR from the infectious molecular clone pNL4-3 
(NIH AIDS Reagent Program 114; GenBank AF324493), and were ligated into the parent 
mammalian expression vector pAcGFP1-N3 (Takara Bio USA) such that GFP is expressed only 
if readthrough of the terminal UGA occurs. Primer design incorporated 5’ NheI and 3’ BamHI 
restriction sites into each of the three amplicons. To access GFP, an in-frame TAA stop codon at 
position 9504, between the two ATI regions, was mutated to CAA. The plasmids, shown 
schematically in Fig. 10, were 1) pNefATI1, which contained nef and only the first of the two 
putative ATI regions, 2) pNefATI2, in which the second tethering region was additionally 
Figure 10: Schematics for the plasmid inserts used to assess nef 3’-UGA readthrough. Regios 
with antisense complementarity to TR1 mRNA are shown crosshatched as ATI1 and ATI2. Naturally 
occurring (TGA, TAA) or engineered (TAG) in-frame stop codons and a CAA mutant of the wild-type 




included, and 3) pNefATIstop, a double-stop negative control in which the stop codon at 9504 is 
retained and a second in-frame stop codon (TAG) is introduced just past the end of ATI2 but 
upstream of GFP, blocking formation of GFP even if readthrough of the UGA occurs. The 
primers (Integrated DNA Technologies, Inc, Coralville, IA; shown 5’ → 3’) included the same 
forward primer CAG GGC TAG CAA AGG ATT TTG CTA TAA CAT GGG TGG CAA G for 
all 3 constructs and reverse primers TGC AGG ATC CGA GGG CTC GCC ACT CC 
(pNefATI1), CCA GAG GGA TCC AGT ACA GGC AAA AAG CAG CTG CTT GTA TGC 
AGC ATC (pNefATI2), and GAG GGA TCC ACT ACA GGC AAA AAG CAG CTG CTT 
ATA TGC AGC ATC (pNefATIstop). Proper assembly of the vector constructs was verified by 
sequencing (Eurofins Genomics, Louisville, KY). 
3.3b Selenium dependence of stop codon readthrough 
To assess the influence of selenium on the readthrough of the terminal UGA codon in nef and 
optimize its concentration in the culture growth media, HEK 293T cells (NIH AIDS Reagent 
Program catalog number 103) were seeded (2 ×104/well) in a black clear-bottom 96-well plate 
(Costar 3603) and incubated for 24 hours in DMEM supplemented with 10% fetal bovine serum 
at 37 0C, 5% CO2 atmosphere, after which the media was replaced with media enriched with 
sodium selenite (0, 20, 50, or 80 nM). After 48 hours the cells were transfected with pNefATI1 
using lipofectamine 2000 (Invitrogen) by addition 50 µL of OptiMEM I (Gibco) containing 0.2 
µg of plasmid DNA complexed with 0.3 µL of cationic lipid to each well. Incubation at 37 0C 
was continued for 12 hours and the media was replaced with fresh Se-enriched media. Four days 
post-transfection fluorescence was measured using a BioTek Synergy Mx microplate reader with 




3.3c Transfection of HEK 293T cells with pNefATI constructs 
HEK 293T cells were transfected with the each of the pNefATI plasmids using the protocol 
described above, except that all incubations contained 20 nM Se (deemed the optimal 
concentration) after the initial 24 hour, Se-free period. The expression of GFP was followed 
using an EVOS cell imaging system. Fluorescence images were taken at 10 different well 
locations for each treatment and the average ± SD of the intensity was calculated using NIH 
ImageJ software[122]. 
3.3d Flow Cytometry Analysis 
HEK 293T cells were seeded in a 6 well plate (5 x 105/well) in 1 ml of media enriched with 20 
nM selenium and incubated for 12 hours. The cells were transfected with pNefATI1 or the parent 
pAcGFP1-N3 plasmid by addition of a complex of 0.5 µg plasmid DNA and 3.5 µL 
lipofectamine in 100 µL OptiMEM I. After 12 hours, the media was replaced with fresh media 
(20 nM Se) and the cells were incubated for 4 days at 37 °C. Cells were trypsinized, washed with 
1% PBS, and resuspended in 400 µl of 0.1% BSA in PBS. GFP expression was evaluated using a 
BD FACSAria III flow cytometer with FACS DIVA version 6.1.3 software.  
3.3e siRNA knockdown of TXNRD1 mRNA 
TXNRD siRNA (Life Technologies 4390824) and the Ambion Silencer siRNA transfection II kit 
(Life Technologies AM1631) were used for the knockdown of TXNRD1 mRNA. Transfection of 
HEK 293 cells with pNefATI1 + siRNA was optimized by using varying volumes of the two 
transfection agents supplied in the Silencer kit, siPORT Amine and siPORT. All incubations 





To initiate an experiment, siPORT Amine (0.6 µL + 25 µL OptiMEM I/well) was mixed with 
pNefATI-1 (0.2 µg + 25 µL OptiMEM I/well). Anti-TXNRD1 siRNA was reconstituted in 
nuclease-free water to a concentration of 20 µM and for each well 0.75 µL was diluted to a final 
volume of 25 µL in OptiMEM I. Aliquots (equivalent to 0.75 µL/well) of GADPH siRNA and 
scrambled siRNA (negative control) from the Silencer transfection kit were similarly diluted in 
OptiMEM I to a final total volume of 25 µL/well. The DNA/siPORT Amine complex solution 
(50 µL/well) and siRNA solutions (25 µL/well) were combined and 75 µL aliquots were placed 
in each well of a 24 well culture plate. Control wells contained 75 µL of OptiMEM with or 
without siPORT Amine and no nucleic acid. HEK 293 cells (5 x 105 in 425 µL media) were 
added to each well. The final concentration of siRNA was 30 nM. Plates were incubated at 37 °C 
for 72 hours. GFP expression was imaged using the EVOS system and fluorescence intensity 
was calculated from 10 images of each well using the NIH ImageJ software. An identical 24 well 
plate was prepared in tandem and used for qPCR analysis to quantify the siRNA knockdown of 
TXNRD1. 
3.3f Quantitating TXNRD1 mRNA knockdown using RT-PCR 
To confirm that the commercial anti-TXNRD1 siRNA was effective in our system, the cells in 
all treatment and control wells were harvested and processed to isolate total RNA (SV Total 
RNA Isolation System, Promega Corp., Madison, WI). cDNA was synthesized using 300 ng of 
RNA as template. As controls, a parallel set of reactions was run without reverse transcriptase 
and one reaction did not contain RNA template. A SuperScript first-strand synthesis system 
(Invitrogen) was used for cDNA synthesis. Power SYBR Green PCR master mix (Applied 
Biosystems) was used for qPCR which was performed on an ABI 7500 Fast PCR system 




600C for 60 seconds for each cycle. Expression of TXNRD1 mRNA in each sample was 
calculated relative to TXNRD1 expression in untreated cells. Values for TXNRD1 expression 
were normalized against expression values for the GAPDH housekeeping gene. The Pfaffl 
equation was used for calculation of relative expression. 
3.3g Western blot probe for nef-GFP protein expression 
1 mL of cold RIPA lysis buffer (10X Millipore, catalog number 20-188, diluted to 1X with 
deionized water) was added for every 5x106 cells in the resulting cell pellets from each 
experimental condition. 10 uL of beta-mercaptoethanol, HaltTM Protease and Phosphatase 
Inhibitor Cocktail (100X, EDTA-free, Thermo ScientificTM catalog number 78441), and a 0.5 M 
EDTA solution (0.5 M EDTA in sterilized deionized water) was added to every 1 mL of cold 
RIPA lysis buffer prior to addition to the cell pellet. The cell pellet was resuspended in this 
solution and vortexed for 10 second intervals, three times each with 30 second intervals in 
between where the samples were incubated on ice. The samples were then sonicated for 15 
second intervals, three times each with 30 second intervals in between each sonication where the 
samples were incubated on ice. The sonicator probe was cleaned using 99% ethanol in between 
each sample to ensure no contamination between the experimental conditions. The samples were 
then placed on a 950C heating block for 5 minutes before being spun down at 16.1xg at room 
temperature for 10 minutes. The supernatant was collected and stored at -800C until further use.        
The Pierce BCA Protein Assay Kit (Thermo Scientific, catalog number 23225) was used to 
determine relative protein concentrations of each experimental sample. The assay was done to 
manufacturers specifications and visualized at 560 nm on a plate reader. Equal amounts of 
protein from each experimental condition were loaded into a 12% Mini-PROTEAN TGX SDS-




Science, catalog number IS5208)). 3 uL molecular weight ladder (SMOBio Enhanced 3-
colorExcelBandTM, catalog number PM2510) was added to one lane as a standard. The gel was 
set up in a BioRad Mini-PROTEAN vertical gel electrophoresis box with running buffer (10X 
Tris/glycine buffer, BioRad catalog number 1610732, diluted to 1X with deionized water) was 
added to the fill lines. An ice pack was placed in the gel box system and the setup was run at 80 
V for 10 minutes and 115 V for 50 minutes. After running, the gel was removed from its cast and 
placed in deionized water along with 4 pieces of filter paper and 1 piece of 0.45 uM pore 
nitrocellulose membrane (BioRad catalog number 1620115) cut to the size of the gel. The wet 
sandwich was placed in the BioRad wet transfer casket and filled to the top of the set up with 
transfer buffer (1X running buffer, 20% methanol). An ice pack was placed inside the apparatus, 
and the transfer was allowed to run at 200mA for 1 hour and 15 minutes. Once the transfer was 
complete, the membrane was removed from the wet transfer casket and rinsed off once in 
deionized water before being blocked in 2% milk protein solution (2% w/v dried milk with 1X 
sterilized PBS) on a shaking table for 1 hour. The blocking solution was removed, and the blot 
was washed 3X for 5 minutes each with 1X sterilized PBS before addition of primary antibody 
(either monoclonal anti-GFP in rabbit (Sigma-Aldrich catalog number SAB2103123-100UL) or 
polyclonal anti-beta Actin (proteintechTM catalog number 20536-1-AP) depending on what 
protein expression was being measured). The blot was allowed to incubate with 10mL of 1:1000 
dilution (in 1X sterilized PBS) of the primary antibody on a shake table at 40C overnight. 
Following this, the primary antibody was removed and the blot was washed an additional 3X 
with 1X sterilized PBS for 5 minutes a piece before 10mL of 1:5000 dilution (in 1X sterilized 
PBS) of secondary antibody (goat anti-rabbit IgG (H+L) Cross-Absorbed Secondary Antibody 




anti-mouse IgG (H+L) Cross-Absorbed Secondary Antibody Alexa FluorTM 700, Invitrogen 
catalog number A21036 for polyclonal beta-actin antibody) was incubated on the blot for 90 
minutes on a shake table at room temperature. The secondary antibody was removed and the blot 
was washed as previously described before being placed in sterilized 1X PBS and visualized on 
gel imager Odyssey CLx (LI-COR) excited at 700 nm with emission measured at 720 nm. 
3.4 Results 
3.4a Readthrough of the HIV-1 nef 3’-UGA stop codon in HEK 293T cells transfected with 
nef-ATI-GFP constructs 
GFP production from two versions of a wild-type HIV-1 nef expression construct designed to 
read past the conserved UGA stop codon into a downstream GFP domain (A and B in Figure 11) 
was compared to that from several controls: a negative control in which an in-frame TAA stop 
codon was inserted between the nef and GFP domains (C in Figure 11), the parent GFP 
expression plasmid as a positive control (D) and a second negative control consisting of 
untransfected cells (E).  The relative GFP production calculated using ImageJ is shown in Panel 
F. Both the ATI1 and ATI1+2 constructs showed highly significant levels of stop codon 
readthrough relative to the negative control ATIstop construct, which was identical to the ATI2 
construct except for two in-frame stop codons designed to prevent further translation into the 
GFP coding region (Figure 11). Differences between results for pNefATI1, pNefATI2 and the 
parent GFP construct (as 100% readthrough control) were all statistically significant at P<0.001. 
Unexpectedly, the inclusion of the second smaller anti-TXNRD1 region ATI2 in the construct 
lead to a decrease rather than the expected enhancement of readthrough (see Discussion). As 








3.4b Selenium dependence of stop codon readthrough 
Figure 12 shows the effect of varying the pretreatment selenium concentration on GFP 
expression from the ATI1 construct, which is a measure of the efficiency of UGA readthrough.  
HEK 293T cells were pretreated with different concentrations of exogenous selenium as sodium 
selenite, ranging from 0 to 80 nM final concentration, prior to transfection with the ATI1 
plasmid. The results from Fig. 3 show that for pNefATI1, even without added selenite, GFP 
expression in standard culture medium is significantly higher than the untreated control (p < 
0.0001). With additional Se supplementation, as seen in Fig. 4, the amount of readthrough 
product more than doubles going from 0 to 20 nM Se, for which the difference is also significant 
Figure 11: Readthrough of the HIV-1 nef 3’-UGA codon. The 
photomicrograph panels A-E show GFP fluorescence in HEK 293T cells, 
transfected with three different ATI plasmid vector constructs and controls. 
(A) pNefATI1; (B) pNefATI2; (C) pNefATIstop; (D) Parent GFP construct; 
(E) Untransfected cells; (F) Bar graph showing the GFP intensity of each 





(a 119% increase, p < 0.0001). However, GFP production levels for 20, 50 and 80 nM Se are not 
significantly different. Thus, at 20 nM of added exogenous Se, the mechanism appears to be 
saturated, as no further increase is observed at higher concentrations.  




3.4c Flow Cytometry Analysis of GFP expression from nef-ATI-GFP constructs vs. controls 
Flow cytometry was used to obtain a more accurate quantitative assessment of the nef UGA 
codon readthrough efficiency in the nef-ATI1 construct, relative to the parent GFP expression 
construct. As shown in Figure 13, the P1 population of cells transfected with pNefATI1 had a 
mean GFP fluorescence of 11,443 ± 1,242, as compared to the background of 1,304 ± 553 in 
untransfected control cells, and 55,076 ± 11,111 in the cells transfected with the parent GFP 
construct (a standard for 100% readthrough efficiency as it lacks any in-frame UGA codon). 
Figure 12: Added selenium enhances stop codon readthrough from the ATI-1 plasmid construct. 
Results show that supplementation of the basal media with additional selenium as sodium selenite has a 
significant effect on the stop codon readthrough, resulting in higher levels of GFP expression. However, 
the maximal readthrough was observed at the lowest level of selenium (20nM) and the readthrough did 
not change significantly at higher selenium concentrations. Even at the 20 nM concentration, addition of 
sodium selenite essentially doubles UGA stop codon readthrough relative to unmodified cell culture 






Figure 13: Flow cytometry analysis of HIV-1 nef stop codon readthrough. Panel A (top) HEK 
293T Cells transfected with pNefATI1 vector. FITC-A represents green fluorescence (GFP). The P1 
population had a mean FITC-A of 11,443 ± 1,242. Panel B (middle) cells transfected with EGFP-N3 
plasmid. The P1 population had a mean FITC-A of 55,076 ± 11,111. Panel C (bottom) untransfected 
cells (background). The mean FITC-A of P1 was 1,304 ± 553. Stop codon readthrough efficiency was 




3.4d siRNA knockdown of TXNRD1 mRNA decreases nef 3’-UGA codon readthrough 
To assess the hypothesized role of thioredoxin reductase 1 mRNA in facilitating the UGA 
readthrough demonstrated in Figures 11-13, anti-TXNRD1 siRNA was used to knock down 
TXNRD1 mRNA levels, which we predict should lead to decreased GFP production from the nef 
ATI1 construct. 
Figure 14 shows the results of a preliminary experiment used to determine the optimal 
transfection reagent and concentrations for the subsequent siRNA studies. This resulted in the 
choice of the siPort Amine at 0.6 µl per well as the transfection reagent for the siRNA TXNRD1 
knockdown experiment shown in Figure 15. 
 
In Figure 15, the effects of 3 different siRNAs on GFP production from the pNefATI1 plasmid 
are shown, as compared to pNefATI1 with no siRNA, and untransfected controls. The three 
siRNAs used were anti-TXNRD1, a random “scrambled” siRNA, and anti-GAPDH as a 
housekeeping gene control.  The results show that the anti-TXNRD1 siRNA produces a 
Figure 14: Selection of transfection reagent and optimization of the transfection reagent volume using 
HEK 293T cells transfected with pNefATI1 EGFP-N3 vector. EVOS GFP fluorescence images A, B, C, D, 
E and F are cells transfected with 0.3 ul amine, 0.6 ul amine, 0.15 ul amine, 0.5 ul NeoFX, 1.2 ul NeoFX and 





significantly greater decrease in pNefATI1-associated GFP production than either the scrambled 
or anti-GAPDH siRNAs. Compared to panel A (GFP production from pNefATI1 with no added 
siRNA), we observe a slight but non-significant decrease in GFP production in the presence of 
scrambled siRNA (panel B), a greater (~50%), significant decrease with the positive control anti-
GAPDH siRNA (panel C; p<0.001), but the largest decrease of ~67% was with the anti-
TXNRD1 siRNA (panel D; p<0.0001). There is no detectable GFP production from the 
untransfected control cells (Panel E). The average GFP values from the different conditions are 














3.4e Validating TXNRD1 mRNA knockdown using RT-PCR 
To validate the siRNA knockdown of TXNRD1 in the previous experiment (Figure 14), 
TXNRD1 expression in cells treated with the anti-TXNRD1 siRNA was assessed using qPCR, as 
compared to TXNRD1 expression in untreated cells, and cells treated with the scrambled siRNA, 
and cells transfected with the pNefATI1 construct alone. As shown in Figure 16, the presence of 
Figure 15: Effect of siRNAs on GFP production from the pNefATI1 construct.  Panels A-E show EVOS 
microscopy images of each transfection condition: A. pNefATI1 with no siRNA. B. With added negative 
control scrambled siRNA. C. With positive control anti-GAPDH siRNA. D. With anti-TR1 siRNA. E. 
Untransfected cells. F. Bar graph showing average GFP expression from 10 images of each treatment 




anti-TXNRD1 siRNA lead to the largest and most significant decrease in TXNRD1 mRNA 
levels in treated cells, a decrease of about 28% under the conditions used (p < 0.0001). In cells 
treated with either the scrambled siRNA or pNefATI1 there was a small (~9%) and less 
significant decrease (p < 0.01) in TXNRD1 mRNA. 










The results of the current study may be summarized as follows: 
• Using full length expression constructs of the HIV-1 nef gene containing downstream 
sequence elements extending as much as 130 nucleotides past the 3’-UGA stop codon, 
cloned upstream of GFP (as a reporter for translational readthrough), we have 
demonstrated that the UGA codon is suppressed at detectable efficiency, estimated by 
Figure 16: TR1 mRNA expression assessed by qPCR. Compared to untreated cells, an 
approximately 27% knockdown of TR1 mRNA relative to untreated cells (P < 0.0001) was observed in 
the sample treated with anti-TR1 siRNA. This confirms the knockdown of TR1 mRNA that may 




FACS analysis to be about 19% by comparison to GFP production from the parent GFP 
construct. 
• The nef expression constructs in question, pATI-1 and pATI-2, contain sequences of 
antisense complementarity to human TXNRD1, identified previously as regions of 
potential antisense tethering interactions (ATI) targeted by HIV-1. The dependence of nef 
3’-UGA readthrough on TXNRD1 mRNA is supported by our finding that, in the 
presence of anti-TXNRD1 siRNA, there is a substantial and significant decrease (~67%, 
p < 0.0001) in UGA readthrough from the nef pATI-1 construct; this decrease is also 
significantly larger than the effect of either of the control siRNAs. This result supports 
our hypothesis that antisense tethering of TXNRD1 mRNA may contribute to the 
translational readthrough.  
• When the Se concentration of the culture media was increased above basal levels by the 
addition of 20nM or greater sodium selenite, nef 3’-UGA readthrough increased by over 
100%, supporting a role for selenium in the readthrough mechanism. However, our 
results do not address the question of whether this is due to the incorporation of Sec at the 
UGA codon, as hypothesized previously [2, 119], or by some other mechanism. A 
western blot probe of GFP expression was performed to address this question but gave 
conflicting results as we see over 100% more GFP expression in the pATI-1 condition 
when supplemented with selenium, but the protein product is the same molecular weight 
as GFP identified from the parent GFP plasmid protein expression. 
These results strongly support our earlier predictions of translational readthrough of the HIV-1 
nef 3’-stop codon, and a potential role for selenium [2]. However, they fall short of 




Sec at the location of the UGA codon. UGA is known to be a very “leaky” stop codon, and 
various amino acids with related codons (e.g. Trp, Cys, Ser) have been observed at this codon 
position in known examples, including mixtures of the various possible products, e.g., as 
reported by Chittum et al for beta globin [123].   
This key finding is also consistent with experimental evidence for an extended isoform of nef 
obtained by researchers at the University of Rochester, NY, in which the nef extension was 
identified by immunohistochemical methods, in both post-mortem HIV+ brain slices and in vitro 
translated nef constructs from actual patient isolates (Dr. Benjamin Blumberg, personal 
communication). 
The evidence presented here obtained using siRNA in regard to a possible role for TXNRD1 
mRNA in the observed readthrough is positive, since there is a significant ~67% decrease (p < 
0.0001) in GFP production from the pNefATI1 construct in the presence of anti-TXNRD1 
siRNA, which is significantly greater than the reduction seen with either the anti-GAPDH 
control or the scrambled siRNA negative control; the decrease seen with the scrambled siRNA is 
not significantly different from no siRNA at all.  The effect of the anti-GAPDH siRNA may 
simply reflect a decrease in overall cell activity produced by the targeting of an essential 
housekeeping gene.  
We verified TXNRD1 knockdown by this commercial anti-TXNRD1 siRNA using RT-PCR, 
which in our hands showed only a 27% decrease in TXNRD1 mRNA levels.  The manufacturer 
claims that the knockdown achieved with this siRNA should be greater, about 70%, which would 
be more consistent with the potency we observed for its effect on inhibition of GFP production 
from the pNefATI1 plasmid (a 67% decrease); however, it is possible that only a 27% decrease 




One important observation is that pNefATI1 produced only a minimal (9%) knockdown of 
TXNRD1 mRNA, similar to that produced by the scrambled siRNA. This is despite the fact that 
pNefATI1 does express an mRNA with a region of antisense complementarity to TXNRD1 
mRNA. However, antisense and miRNA type interactions do not necessarily lead to degradation 
of a target mRNA, which depends on a high degree of complementarity of the 2 RNAs; when the 
antisense interaction is not perfect, it can be the basis of ribosomal interference with the target 
protein synthesis, without mRNA degradation [124]. Thus our results suggest that the antisense 
targeting of TXNRD1 mRNA by the HIV-1 nef 3’-region, in addition to serving a possible 
tethering function for TXNRD1 SECIS capture [2], may also lead to inhibition of TXNRD1 
protein synthesis in infected cells, but not via degradation-mediated downregulation of TXNRD1 
mRNA. 
One unexpected result was that the readthrough efficiency was LESS when both anti-TXNRD1 
ATI regions were present in the nef construct, as opposed to just ATI1 alone.  Because in nef 
ATI1 the 3’-UGA is right near the center of an ~40 residue sequence that is complementary to a 
region of TXNRD1 mRNA, during translation up to and past the stop codon, which we have now 
shown does occur (Figs. 3, 4 and 5), ATI1 would have to become unwound as that region of the 
nef mRNA enters the ribosome.  Thus, we suspected that the second downstream ATI region, 
though smaller (only 13 base pairs in length), might be important to keep the TXNRD1 mRNA 
and its SECIS element in proximity to the ribosome. However, it is also possible that the 
dynamics of the engagement of the TXNRD1 SECIS to the ribosome are such that they could 
continue to function in the recoding of the heterologous viral UGA, for at least a short time after 
the unwinding of ATI1. So ATI2 may not be particularly important. But it is also possible that 




simply due to the fact that, in order to engineer this construct to include the ATI2 region, while at 
the same time permitting readthrough into the downstream GFP region, a region of viral 3’-RNA 
that normally has non-coding roles must be translated. Thus, codon usage in this region may be 
non-optimal, affecting translation efficiency in our ATI2 construct. In contrast, readthrough of 
the 3’-UGA, which we have now observed in transfected cells, would by necessity lead to C-
terminal extension of the nef coding region by up to 33 amino acids, so that extended nef codon 
usage in the entire region spanning ATI1 has presumably been optimized for efficient translation 
during viral evolution. That is not the case for the region spanning ATI2, due to the TAA stop 
codon at its 5’ end. In addition, the noncoding far 3’-end of the HIV-1 mRNA contains a number 
of RNA hairpin structures with diverse regulatory functions, the unwinding of which might slow 
translation around the ATI2 region. 
An alternative explanation for GFP expression from these constructs could involve initiation of 
GFP protein translation at an internal start codon. Although there is a candidate methionine in the 
N-terminal region of the GFP coding sequence, there are no in-frame Met codons past the 3’-
UGA of nef in any of the included viral sequences. Hence, the possibility of internal initiation of 
GFP synthesis fails to explain our observations, because if it was happening from the GFP 
internal Met, GFP production would also be observed with the pNefATIstop control construct, 
which is not the case.  
Finally, it must be emphasized that the current results showing a link between selenium biology 
and the expression of an isoform of a gene (nef) that is central to HIV-1 pathogenesis should be 
interpreted in the light of an extensive body of evidence linking HIV disease progression and 
outcome to selenium status. Observations of selenium abnormalities in AIDS patients date back 




linked HIV-associated mortality risk to serum selenium levels [105, 127, 128], and demonstrated 
various clinical benefits for selenium supplementation, either alone or as part of a micronutrient 
formulation [114, 115, 129].  
Nor is HIV-1 an exceptional case in this regard. A number of predominantly RNA viruses have 
been shown in animals or humans to have either increased frequency and/or severity of cases in 
low selenium areas or individuals, or some measurable clinical or survival benefit from selenium 
supplementation (as reviewed, [14, 130, 131]). The most recent example is seen with the 
COVID-19 pandemic, for which Zhang et al. have now demonstrated a highly significant 
association between the outcome of SARS-CoV-2 infection and previously documented regional 
selenium status in Chinese cities [132].  
Based on our results to date, and as proposed previously [21], we predict that antisense 
interactions with TR isoforms will be identified for a number of other RNA viruses, and that this 
may prove to be a general mechanism for RNA viruses to enhance RNA levels for virus 
production, by partially inhibiting the conversion of ribonucleotides to 2- deoxyribonucleotides. 
Because ribonucleotide reductase uses the thioredoxin system as a hydrogen donor, antisense 
knockdown of TR isoforms could tip the balance in favor of RNA production, by inhibiting the 
regeneration of reduced thioredoxin. This biochemical role of selenium in mammals may prove 
to be a significant factor contributing to the increased virulence of some RNA viruses in 
selenium-deficient hosts. 
3.6 Conclusions 
We have provided compelling evidence that sequences within the HIV-1 nef mRNA, with its 




extension of the nef protein into the downstream region. The only non-native element introduced 
into the pNefATI1 construct was mutation of the TAA stop codon at the end of that extension 
region, in order to permit translation of the downstream GFP reporter gene. We have also 
demonstrated that addition of a low concentration (20 nM) of selenium as sodium selenite can 
increase the readthrough efficiency by over 100%, and that knockdown of TXNRD1 mRNA can 
reduce the efficiency of the stop codon readthrough by about two-thirds.  These findings are 
consistent with a role for TXNRD1 mRNA and selenium-based cellular mechanisms in the 
readthrough event, but further studies will be required before we can say that virus/host mRNA 
tethering reactions are definitely involved in these observations – however, it has been 
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4.1 Abstract 
Rapid and reliable recognition of nucleic acid sequences is essential to a broad range of fields 
including genotyping, gene expression analysis, and pathogen screening. For viral detection in 
particular, the capability is critical for optimal therapeutic response and preventing disease 
transmission. Here, we report on a novel approach to the detection of identifying sequence motifs 
within single-strand DNA and RNA viral genomes based on solid-state nanopores. By designing 
DNA oligonucleotide probes with complementarity to target sequences within a target genome, 




tagged duplex molecules the same length as the probe only if the target is present. The product 
can subsequently be bound to a protein chaperone and analyzed quantitatively with a selective 
solid-state nanopore assay. We first use a model DNA genome (M13mp18) to validate the 
approach, showing successful isolation and detection of multiple target sequences 
simultaneously. We then demonstrate the protocol for the detection of RNA viruses by 
identifying and targeting a highly conserved sequence within human immunodeficiency virus 
(HIV1-B). 
4.2 Introduction 
Viruses are nanoscopic particles containing genetic material that must invade living organisms 
and take over their cellular machinery to replicate. In support of this mechanism, they can be 
both highly transmissible and rapidly mutating, enabling them to evolve quickly. From the 
identification of Yellow Fever virus as the first reported human virus in 1901, viruses have been 
a consistent threat to human health. Indeed, three to four new species of human virus are 
identified every year accounting for over two-thirds of new human pathogens [133-136]. In 
recent history, diverse diseases have emerged from viral vectors including human 
immunodeficiency virus (HIV), Ebola, avian influenza (H7N9, or bird flu), Zika, and middle east 
respiratory syndrome (MERS) [137, 138]. Enhanced global movement has further exacerbated 
the problem of rampant transmission, increasing the likelihood of global pandemics like the one 
caused by SARS-CoV-2 beginning in 2019 [139]. 
Viral detection capabilities are critical for combating the spread of such diseases, providing both 
accurate diagnosis for early treatment planning and a means of performing contact tracing for 
containment [138]. While a broad range of diagnostic approaches exist for this purpose, current 




chain reaction (PCR) – including quantitative PCR (qPCR) and reverse transcription PCR (RT-
PCR) – are considered gold standards in viral diagnostics [138, 140]. While these techniques are 
highly sensitive, however, they can also feature a risk of contamination and bias, commonly rely 
on expensive optical systems for analysis, and are often slow. Indeed, the typical hours-long 
cycling necessary for most PCR assays is a critical factor limiting throughput and increasing 
time-to-answer [141, 142]. Alternatively, immunoassays are also used extensively to identify 
protein markers associated with viral exposure. While high sensitivity can be achievable through 
several measurement modalities including fluorescence, radiolabeling, and colorimetric 
(biochemical), immunodetection also relies on expensive reagents and can suffer from cross 
reactivity, resulting in false negatives or false positives [143-146]. Finally, recent developments 
have been made in the application of next-generation sequencing (NGS) and mass spectrometry 
to viral diagnosis. While promising, these approaches remain nascent, hinging currently on 
expensive instrumentation and computationally-demanding analyses [138, 146]. 
An emerging platform for biomolecular analysis is the solid-state (SS-) nanopore [147, 148]. 
Briefly, a SS-nanopore is comprised of a thin, insulating membrane supported by a silicon chip 
and featuring a single, nanometer-scale pore. When the membrane is used as a partition between 
reservoirs of electrolyte solution, the application of a voltage bias across it generates an electric 
field that can facilitate the electrokinetic movement of charged molecules through the opening. 
Each translocation temporarily interrupts the measured ionic current and results in a signal (or 
‘event’) that can be exploited for biosensing and molecular evaluation. SS-nanopores have been 
employed extensively to identify nucleic acids, proteins, biological nanoparticles (e.g. 
exosomes), and synthetic nanoparticles [149-157]. Recently, the platform has also been applied 




including Paramecium Bursaria Chlorella virus (PBCV-1), Hepatitis B, HIV, and influenza [158-
165]. However, probing whole viruses does not explicitly provide a route to viral discrimination 
without a priori knowledge of the pathogens present in a fluid and therefore the translational 
potential of these approaches has been narrow. The alternative approach of detecting specific 
viral biomarkers has been explored with the platform as well. For example, Niedzwiecki, et al. 
studied nucleocapsid protein 7, a protein constituent specific to HIV, by probing the effect of 
binding to a synthetic RNA on its translocation dynamics. However, the use of SS-nanopores to 
detect nucleic acid (sequence-based) viral bioindicators has been more challenging. This is at 
least in part because the platform itself lacks intrinsic selectivity: since all passing molecules 
produce a signal conventionally, differentiation of particular target sequences is difficult [166, 
167].  
To address this gap, our group has established a novel approach to detect and quantify targeted 
nucleic acid sequences [168]. Briefly, the two-component assay employs a short nucleic acid 
fragment (<~250 bp) featuring a single biotin tag and a small, globular protein (54 kDa 
monovalent streptavidin, or MS) [169, 170]. When each is introduced individually to a SS-
nanopore of appropriate size (typically ~7.5-11 nm diameter), they do not yield significant 
events due to their small size and rapid transit time (Figure 1a-b). On the contrary, when bound 
together to form a nucleoprotein complex, the larger structure interacts sterically with the pore 
walls to slow the translocation speed and produce translocation events (Figure 18C). We 
previously extended this basic assay to allow the detection of nucleic acid sequences by 
exploiting the observation that events are generated by protein-bound duplex constructs but not 
single-strands bound to protein [171]. Through introduction of a biotin-labeled DNA probe to a 




are present, yielding specific detection of target sequences. However, to date, this detection has 
been demonstrated only for naturally short, single-strand nucleic acids like microRNAs, for 
which the probe can be matched in size to the target. 
 
In this report, we expand our protocols to enable the SS-nanopore assay to detect conserved 
sequence motifs within large single-strand genomes, including viral genomes. Our strategy, 
which involves annealing to a synthetic probe sequence and subsequent digestion of non-target 
regions, yields a short duplex construct capable of binding to MS and consequently being 
analyzed by our SS-nanopore assay. Like PCR, high specificity is achieved through Watson-
Crick base pairing, but our approach provides potential advantages in both time and cost. We 
validate the technique using a model DNA genome (M13mp18 bacteriophage DNA) and then 
demonstrate its extension to RNA, the more common carrier of viral genetic information, by 
probing a conserved sequence in HIV. The ability of our approach to assess target sub-sequences 
within large DNAs and RNAs suggests the potential value of SS-nanopores not only for viral 
identification but also for other nucleic acid detection applications as well. 
Figure 17: Selective solid-state nanopore assay. Diagrammatic representation (top) and example conductance 
trace (bottom) for the translocation of (a) individual biotinylated duplex nucleic acids, (b) monovalent 
streptavidin protein, and (c) duplex nucleic acids bound to monovalent streptavidin. Individual constituents 
transit through the nanopore rapidly and yield no events (a-b) while the nucleoprotein complex results in an 
event cascade due to steric hinderance.  DNA translocations performed with a synthetic 60 bp construct and all 




4.3 Materials and methods 
4.3a Biomolecules  
All synthetic oligonucleotides, including all synthetic probes and complementary sequences used 
to form control constructs were obtained commercially (Integrated DNA Technologies, 
Coralville, IA). The sequences of all probes are listed in Supplementary Table S1. All the 
oligonucleotides were resuspended in deionized water free of DNAse and RNAse (Invitrogen, 
Grand Island, NY) to a stock concentration of 200 µM and stored at -20oC before use. single-
stranded M13mp18 (New England Biolabs, Ipswich, MA). Synthetic duplex constructs were 
formed by annealing complementary oligonucleotides at a molar ratio of 1:1, heating to 95oC for 
10 minutes, and slowly cooling to room temperature.  
HIV-1 BH10 non-infectious molecular clone (pBH10) was obtained from the NIH AIDS 
Reagent program (catalog #90) and subcloned into the SstI site of SP64 vector (Promega, 
Madison, WI) as a competent bacterial culture that was stored in glycerol stock at -80oC prior to 
use [172]. 50 uL of bacterial stock was plated on an LB agar plate with a 50 ug/mL concentration 
of ampicillin and grown overnight in a bacterial incubator at 37oC. Formed colonies were 
isolated, transferred to 5 mL of LB with 5 uL of 10mg/mL ampicillin, and then put in a shaker 
(135 rpm) at 37oC for 12-16 hours until reaching an optical density (A600) between 2-4. The 
bacterial culture was spun down at 5,000x G at 4oC for 20 minutes to form a bacterial pellet 
which was isolated and used as a source for plasmid DNA using the Wizard SV Mini Prep 
Plasmid DNA Purification kit (Promega). 1 ug of the purified pbH10 plasmid was mixed with 1 
U of NheI (New England Biolabs) and 3 µL of 10X NEBuffer 3.1 (New England Biolabs) in a 
30 µL aliquot and incubated at 37oC for 1 hr to cut the DNA downstream of the SP6 promoter 




analyzed on a 1% agarose gel to ensure successful linearization. The linearized DNA was then 
processed with the HiScribe™e SP6 RNA Synthesis Kit (New England Biolabs) to synthesize 
full-length viral RNA product following the manufacturer’s suggested protocol. 1 uL of 
SUPERase•In™ RNAse inhibitor (Invitrogen) was added prior to sample storage at -20oC for 
stability. For all RNA processing steps, nuclease-free reagents were employed and work was 
carried out in an Airclean PCR workstation (AirClean Systems, Creedmore, NC) to reduce 
contamination. 
4.3b DNA sequence isolation protocol  
Annealing was carried out by mixing synthetic probes and M13mp18 DNA at a molar ratio of 
13:1 in water, heating to 95oC for 10 minutes, and then slowly cooling to room temperature. 
Digestion of unconjugated regions of M13mp18 and the excess probes was performed by adding 
20 U MBN (New England Biolabs) for every 2.5 µg of M13mp18, adding 10X MBN Reaction 
Buffer (New England Biolabs) to reach a final concentration of 1X, and incubating the mixture at 
30oC for 15 mins. Endonuclease activity was quenched by adding an equal volume of 
phenol/chloroform/Isoamyl alcohal (25:24:1) (Acros Organics, Morris, NJ) followed by 
centrifugation at 17,000g in phase lock gel tubes (Quantabio, Beverly, MA). The process was 
repeated once using pure chloroform to remove any residual phenol. The aqueous component 
containing DNA isolate was retrieved and further purified using a Nucleotide Purification Kit 
(Qiagen, Germantown, MD). Obtained DNA constructs were redispersed in DNAse-/RNAse-free 
water at a final concentration of 150 nM and diluted as needed for concentration-dependent 
studies. The samples were loaded on a 3% agarose gel in 1X TBE buffer with Gel Red nucleic 
acid dye (Phenix Research Products, Candler, NC) and imaged by GelDoc™ system (BioRad, 




4.3c RNA sequence isolation protocol  
The multiple sequence alignment program Kalign (European Informatics Center) was used to 
align sequences of HIV-1B for identifying a candidate probe [173]. 4,300 full genome sequences 
of HIV-1B retrieved from Los Alamos National Laboratory (LANL) database were considered 
ranging in collection year and geographical area to maximize precision of the conserved 
sequence [174]. The target conserved motif was selected from candidate sequences with more 
than 90% alignment among all considered genomes. Annealing was performed using the same 
conditions as employed for M13mp18 but with a molar ratio of probe to RNA of 1:40. 
Magnesium chloride was added to the annealing mixture at a final concentration of 200 µM to 
enhance stability of duplex by screening the negatively charged phosphate backbones of the 
nucleic acids. After annealing, 0.2 U MBN was added for every 10 µg of RNA, 10X MBN 
Reaction Buffer was added to reach a final concentration of 1X, and the mixture was incubated 
for 15 mins at 30oC. All other steps were followed as for M13mp18 above except that the use of 
the nucleotide removal kit for purification was replaced with an ethanol precipitation step to 
reduce contamination from spin columns and buffers. The obtained heteroduplex products were 
redispersed in DNAse-/RNAse-free water at a final concentration of 320 nM and diluted as 
needed for concentration-dependent measurements. Products were analyzed by gel 
electrophoresis as with M13mp18 as above but with the electrophoretic cells cleaned using a 







4.3d Binding reaction between biotin tagged biomolecules and MS  
Monovalent streptavidin (MS) was supplied by Howarth lab (Oxford University). For all binding 
reactions, duplex constructs were reacted with MS at a molar ratio of 1:4 in 1X PBS and 
incubated for 10 mins at room temperature [175]. The RNA-DNA hybrid construct was 
incubated with MS in a 1:40 molar ratio. 
4.3e Solid State nanopores  
4×4 mm silicon chips with a frame size and 20 µm silicon nitride window were obtained 
commercially (Norcada, Alberta, Canada). RNA measurements were performed on devices with 
30 nm thick membranes while all other measurements shown used 20 nm thick membranes. In 
each membrane chip, a single nanopore 7.5-10 nm in diameter was fabricated using a scanning 
helium ion microscope (Orion PLUS, Carl Zeiss, Peabody, MA) technique described elsewhere 
and stored in 50% ethanol prior to use [176]. Directly before a measurement, chips were rinsed 
with ethanol and HPLC grade water, dried under filtered air flow, and cleaned with air plasma 
(30W) for 2 mins on each side to promote hydrophilicity. The silicon chip was then placed into a 
custom 3D printed flow cell and immediately introduced with measurement buffer (900 mM 
NaCl, 0.5X PBS) on both sides. For application of voltage and measurement of current, Ag/AgCl 
electrodes were immersed into the solution on each side and connected to a patch-clamp 
amplifier (Axopatch 200B, Molecular Devices, San Jose, CA). Pore diameters were verified 
through analysis of a linear current-voltage curve and comparison to a standard model [177]. 
Translocation measurements were carried out by replacing the measurement buffer in the cis 
chamber with analyte in measurement buffer. All current traces were collected at a bandwidth of 
200 kHz with a 100 kHz four-pole Bessel filter and analyzed using custom software through 




analyzing discrete 3.2 s blocks of data to identify events as defined by signals exceeding a 
threshold amplitude of 4.5σ and having a duration between 12.5 µs and 2 ms. 
4.5 Results and discussion 
4.5a Internal sequence isolation  
 
Our general approach to produce biotinylated duplex constructs from single-strand genomes is 
shown schematically in Figure 18a. First, a short target region is identified within the genome 
(Figure 18a (i), red) and used to design a complementary probe construct (Figure 18a (i), green) 
Figure 18: Visualization of the product from the digestion of hybridized molecular probe to genome. (a) 
Schematic representation of steps involved in the isolation of sub-sequences from a single-strand genome. A 
long genome (i) containing a target sequence motif (red) is annealed (ii) to a complimentary monobiotinylated 
DNA probe (green). The resulting construct is then subjected to digestion with a single-strand specific 
endonuclease (mung bean nuclease or MBN, iii) to yield a monobiotinylated duplex. (b) Agarose gel 
electrophoresis analysis. M13mp18 DNA alone (lane 1) is fully digested by MBN (lane 2). When annealed to a 
monobiotinylated 60 nt DNA probe, the same treatment yields a 60 bp duplex product (lane 5) that shifts upon 






consisting of a synthetic DNA oligonucleotide with a single biotinylated base. This probe is then 
mixed with the genomic material and subjected to a single thermal cycle to promote annealing, 
resulting in constructs that are locally duplex at the target site but single-strand elsewhere 
(Figure 18a (ii)). Finally, the constructs are incubated with mung bean nuclease (MBN), an 
endonuclease that catalyzes the degradation of internal phosphodiester bonds specifically in 
single-strand nucleic acids [178]. This treatment digests un-annealed genomic regions (Figure 
18a (iii)) but leaves the target sequence intact, yielding duplex fragments matched in length to 
the synthetic probe and retaining the biotin tag for downstream analysis (Figure 18a (iv)). Note 
that positioning of the biotin near the center of the DNA probe reduces the chance of inadvertent 
MBN digestion due to thermally-driven structural fluctuations (or “breathing”) of the duplex 
product at its ends.  
We established our protocol initially using as a template a model single-strand DNA genome 
derived from the bacteriophage M13mp18 (7249 nt in length). For a first demonstration, we 
employed a 60 nt synthetic biotinylated probe designed with complementarity to an internal 
motif of M13mp18 (see Materials and methods) and determined assay success through gel 
analysis.  M13mp18 alone yielded a well-defined band in the gel (Figure 18b, lane 1). Upon 
incubation with MBN (Figure 18b, lane 2), we observed a total loss of features in the lane, 
confirming the ability of the nuclease to digest the single-strand genomic DNA completely. 
Repeating the same procedure after annealing the biotinylated 60 nt probe to M13mp18 (Figure 
18b, lane 5), we instead observed a distinct band that ran to the same position as a synthetic 60 
bp construct (Figure 18b, lane 3), showing that the 60 bp construct is successfully isolated. 
Some low-molecular weight material was also seen following isolation (Figure 18b, lane 5 




digest due to their local duplex nature. Subsequent binding of the isolate to MS yielded a shift 
(Figure 18b, lane 6) identical to that of the synthetic construct (Figure 18b, lane 4), verifying 
the retention of an active biotin following nuclease treatment. Note that no shift was observed in 
the low-molecular weight products (Figure 18b, lane 5 bottom), indicating that they were 
composed of remnant template fragments rather than excess biotinylated probe. 
MBN incubation time was critical for successful target isolation. When insufficient time or 
enzyme concentration were used, single-strand overhangs remained at the ends of the products as 
indicated by a smeared band on gel (Figure , Appendix C). This could negatively impact 
downstream processes. Conversely, extended incubation times could induce a loss of observed 
product (Figure , Appendix C). Even though the specificity of MBN for single-strand DNA is 
~30,000× more than for duplex, deterioration could be driven by breathing at the ends that could 
provide stochastic single-strand recognition points for MBN activity [179]. 
4.5b SS-nanopore detection of target DNA motifs  
Having demonstrated successful isolation of a target sub-sequence from a large single-strand 
DNA genome, we next demonstrated the viability of the isolated constructs to be analyzed with 
our selective SS-nanopore assay. We first performed a series of voltage-dependent measurements 
of translocation event rates on both the 60 bp product of M13mp18 isolation and MS alone 
(Figure 19a, black and green). We found that neither produced significant signals up to at least 
400 mV. However, when combined, the resulting nucleoprotein construct produced clear events, 
the rate of which increased exponentially with applied voltage (Figure 19a, blue). These 
contrasting signals were in agreement with our past measurements using fully synthetic 
constructs and demonstrated our ability to detect a target internal DNA motif using the assay 




was more than an order of magnitude higher than the rates of either constituent alone under all 
conditions.  
We next conducted a concentration-dependent analysis to investigate quantitation with our assay. 
Using a single applied voltage (300 mV), we first performed a series of measurements on the 
biotinylated 60 bp M13mp18 product bound to MS. Across a range of 1 to 100 nM, we observed 
a linear trend in the measured event rate with a slope of 0.020 ± 0.001 nM-1s-1 (Figure 19b, 
blue). This trend matched our previous results with the same assay and was in quantitative 
agreement with similar measurements performed on a synthetic biotinylated 60 bp DNA 
construct bound to MS, which yielded a slope of 0.022 ± 0.002 nM-1s-1 (Fig. 3b, blue) [180]. The 
close correspondence demonstrated that our isolation protocol yielded an intact duplex DNA 
construct capable of SS-nanopore assay detection and indicated that targets could be quantified 
directly from event rate. Considering the low noise floor (i.e. the number of events associated 
with control measurements), we found that concentrations as low as 1 nM could be resolved 
easily without further improvement. Given the low fluid volume used in our system (10 μL), this 






4.5c Isolation and detection of multiple target motifs in a single genome  
Because MBN is an endonuclease and does not require 3’ or 5’ ends to initiate, it should be 
possible for single-strand regions between multiple annealed probes along a single template 
molecule to be digested, thereby yielding multiple discrete products from one genome. To test 
this approach, we next repeated our isolation protocol with M13mp18 using three distinct 
synthetic probes. For easy differentiation on gel, three biotinylated probes with different lengths 
were utilized: the same 60 nt probe sequence employed above, as well as a 50 nt and a 75 nt 
probe with complementarity to disparate regions of the genomic sequence (see Materials and 
methods). Implementing an isolation protocol identical to that described above for M13mp18 
but including all three probes during the anneal step, we subsequently observed three separate 
bands on gel (Figure 20a, lane 1), demonstrating the isolation of discrete products 
simultaneously. To verify the identities of these bands as the intended target constructs and to 
Figure 19: SS-nanopore analysis of 60 bp constructs isolated from M13mp18 DNA. (a) Measured 
translocation event rate vs applied voltage for MS alone (400nM, green), biotinylated 60 bp M13mp18 isolate 
(100 nM, black), and the combination following co-incubation (blue). Solid lines are exponential fits to the data. 
Inset: example current traces for each group recorded at 400 mV (colors matched). (b) Concentration 
dependence of event rate for biotinylated 60 bp M13mp18 isolate (blue) and a synthetic biotinylated 60 bp DNA 




confirm the retention of the biotin tags, two versions of the isolation procedure were performed: 
one in which biotinylated 60 nt probe and unlabeled 50 and 75 nt probes were used and one in 
which all three probe lengths were biotinylated. After mixing the resulting products with MS, we 
observed that only the center band shifted for the product of the first treatment, validating 
selectivity of the protocol. For the second treatment, all bands were found to shift, demonstrating 
consistent retention of the biotin moiety in all cases. In principle, this same process could be 










For the purpose of quantifying target genomes with our SS-nanopore assay, the simultaneous 
probing of multiple target sequences could provide a critical route to signal amplification without 
the need for PCR; when each genome provides multiple products, the overall sensitivity of 
detection should be improved concomitantly. We next demonstrated this concept empirically. 
Because translocation event rate is known to vary with construct length in our assay, the three 
probes used above for gel visualization could not be employed effectively here. Instead, we used 
two biotinylated synthetic probes of the same length (60 nt) that recognized different regions of 
M13mp18 (see Materials and methods) [180]. The biotinylated products of isolation for both 
probes were first confirmed on gel. When two probes were included in the anneal step, we 
retrieved a single band at the 60 bp position (Figure 20b, lane 1). While the brightness of the 
Figure 20: Isolate and analysis of multiple distinct products from a single-strand genome. (a) Gel analysis. 
Lane 1: isolated products from M13mp18 three DNA probes (50, 60 and 75 nt). Lane 2: electromobility shift 
assay in the presence of MS when only the 60 nt probe is biotinylated. Lane 3: electromobility shift assay in the 
presence of MS when all probes are biotinylated. (b) SS-nanopore assay signal amplification through the use of 
multiple probes. Concentration-dependent event rates for products of M13mp18 isolations using two 
independent biotinylated 60 nt probes separately (solid and open squares) and for products using both 60 nt 
probes in tandem (half solid and half white square) after binding with MS. All measurements performed at 





observed band suggested qualitatively that more product was generated, the common size of both 
constructs made deconvolution challenging. To address this, we also performed the same 
isolation procedure with one biotinylated and one unmodified probe. In this case, binding to MS 
shifted only one of the two products (Figure 20b, lane 2), confirming that both target sequences 
were isolated independently. For completeness, when both probes were biotinylated, both were 
found to shift to a single position upon MS binding (Figure 20b, lane 3), as expected.  
We next analyzed these products both separately and in tandem by SS-nanopore. When either 60 
nt probe was used individually (Figure 20c, open, and solid squares), we observed a 
concentration-dependent event rate that was identical both to previous measurements (see Figure 
19b) and to each other, exhibiting a slope of 0.026 ± 0.004, and 0.024 ± 0.003, respectively. 
However, when both probes were included concurrently, we recorded a dependence that was 
approximately double that of the single-probe measurements (Figure 20c, half solid and half 
open squares), yielding a slope of 0.042 ± 0.003. This confirmed that signal amplification could 
indeed be achieved through the use of multiple probes having complementarity to different 
regions of a single genome. 
4.5d Detection of RNA sequence motifs 
We finally extended our approaches toward pathogen detection by examining a viral genome. 
Because single-strand RNA viral genomes are significantly more abundant than single-strand 
DNA viruses, we chose to apply our protocols and subsequent nanopore analysis to a RNA 
genome. Here, we focused on HIV, a lentivirus (subcategory of retrovirus) consisting of an 
enveloped single-strand RNA. HIV is categorized into two types – HIV-1 and HIV-2 – with the 
former being a more virulent and major cause of infections globally [181, 182]. For this study, 




Americas, Western Europe, Australia, and Asia [183]. While our DNA model M13mp18 had a 
stable, well-documented genome, HIV-1B is known to undergo mutation, making identification 
of a highly conserved target sequencing more challenging. We therefore first performed a 
sequence alignment of -4300 known variants. From this list, we identified a 60 nt motif in HIV-
1B that was more than 90% conserved among all available sequences and designed a 
complementary biotinylated 60 nt DNA probe for use in our isolation protocol.  
As an initial check, we performed an independent test of MBN nuclease on HIV-1B RNA alone 
because minimally the MBN digestion step of our procedure must degrade all of the template 
genome. Some available literature has reported that MBN activity is similar for DNA and RNA 
substrates, suggesting that our existing approach for isolation from DNA should hold [178, 184]. 
In contrast, Kole, et al. found that esters of ribonucleotides are cleaved by the enzyme 100 times 
faster than deoxyribonucleotides due to the presence of a 2’-hydroxyl group, suggesting that a 
significantly lower MBN exposure would be required for an RNA genome [185]. To test this 
directly, we performed a titration series of HIV-1B RNA against MBN (Figure , Appendix C) 
and found a sufficient level of degradation (Figure 21a, lane2) for the same incubation time as 
M13mp18 DNA but with a 400-fold lower concentration.  
Taking this difference into account, we performed the full isolation protocol after annealing 
HIV-1B RNA with the biotinylated 60 nt probe and observed efficient recovery of the 
heteroduplex (RNA-DNA hybrid) product (Figure 21a, lane 5). We also observed an additional 
band below the 60 bp product that corresponded to unconjugated probe. Because of the strong 
reduction in MBN concentration used here, single-strand probes that were digested by the 
nuclease under DNA conditions were left largely intact. However, because single strand nucleic 




not consequential to subsequent analyses [179]. As above, binding of the product with MS 
yielded an electromobility shift in gel analysis (Figure 21a, lane 6) that matched the behavior of 
a synthetic biotinylated DNA duplex (Figure 21a, lanes 3-4) and confirmed the presence of the 
biotin in the final constructs. To demonstrate the viability of our overall approach for RNA 
analysis, we finally conducted our SS-nanopore assay with the HIV-1B isolate. Figure 21b 
shows the result of concentration-dependent event rate measurements using the biotinylated 
heteroduplex product. We again find a linear relationship exhibiting a slope of 0.029±0.001. This 
result demonstrated extraordinary consistency with our measurements on M13mp18 above (c.f. 
Figure 19b), indicating that the sensitivity for RNA genomes should be identical to that of DNA 
genomes. As an additional control, we also measured 
 biotinylated 60 nt single-strand DNA probe bound to MS at a very high concentration (100 nM) 
and found that even that extreme amount yielded an event rate about an order of magnitude less 
than that of the duplex construct (Figure 20b inset). This confirmed that the undigested probe 









In this study, we have reported a new approach for the isolation of sequence motifs from single-
strand genomes and their subsequent detection using a selective SS-nanopore assay. For 
isolation, a synthetic, biotinylated DNA oligonucleotide probe was designed with 
complementarity to a known sequence in the target genome. After annealing, the unpaired 
portions of the genomic template were digested using a single-strand specific endonuclease, 
resulting in duplex constructs matched in length to the probe. Because of the incorporated biotin 
moiety, these duplexes were amenable to analysis with a SS-nanopore assay in which the 
presence of a bound MS protein enables selective detection. We first demonstrated the approach 
Figure 21: Sequence isolations and concentrations-dependent event rates for biotinylated HIV-1B RNA 
constructs. (a) Gel analysis of sequence isolation from HIV-1B RNA. Lane 1: HIV-1B RNA alone. Lane 2: 
HIV-1B RNA after MBN digestion. Lane 3: Synthetic biotinylated 60 bp DNA. Lane 4: Synthetic biotinylated 
60 bp DNA bound to MS. Lane 5: biotinylated 60 bp RNA/DNA heteroduplex isolated from HIV-1B RNA. 
Lane 6: biotinylated 60 bp RNA/DNA heteroduplex isolated from HIV-1B RNA bound to MS. (b) 
Concentration-dependent event rate for monobiotinylated 60 bp RNA/DNA heteroduplex isolated from HIV-1B 
RNA bound to MS measured at 300 mV. Solid line is a linear fit to the data. Inset: event rates for 1: HIV-1B 
isolate alone (100 nM), 2: MS alone (4 µM), 3: 60 nt DNA probe bound to MS (100 nM), and 4: HIV-1B isolate 




using as a model the single-strand bacteriophage DNA M13mp18, showing quantitative 
assessment of a single motif and extending to multiple independent sequence motifs in a 
common genome. We then applied the same concept to human pathogen detection by probing 
the HIV-1B genome. After adapting our protocols to work with RNA, we isolated a highly 
conserved sequence from the genome and observed similar results as with the DNA target, 
showing an ability to sense as little as 10 femtomoles of motif (and thus HIV-1B genomes) using 
only a single probe sequence. 
Our method offers potential advantages over standard methods like PCR in that it is quantitative 
while being all-electronic (i.e. more cost effective than optical readouts) and could offer faster 
time-to-answer as it explicitly does not require amplification and the thermal cycling it entails. In 
addition, because we are able to probe RNA directly, our process does not require reverse 
transcription into cDNA prior to analysis. Ultimately, our results expand the capabilities of the 
approach and its associated protocols beyond the detection and quantification of short, size-
matched targets like microRNA to include any single-strand targets [171]. This will enable 
numerous additional applications including pathogen screening of viral genomes, phylogeny and 
taxonomy assessments using ribosomal RNA, and transcriptional analysis of messenger RNA. 
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Figure A1: IntaRNA-predicted RNA-RNA interactions between Zika virus mRNA and regions of 
unspliced selenoprotein pre-mRNAs, confirming matches shown in Figure 5. Panal A shows the 
predicted interaction between a 3’ region of the ZIKV mRNA (polymerase coding region) and a region 
of SePP1 pre-mRNA, spanning an intron/exon boundary in SePP1. This is essentially the same 
structure predicted by RNAHybrid shown in Figure 5, but slightly truncated at the SePP1 3’ end.  The 
SePP1 intron/exon boundary is indicted by the >< symbol above the sequence. For this analysis, a 500-
base fragment of ZIKV (9,501-10,000) was scanned vs. a 2,000-base fragment (8,001-10,000) of the 
SePP1 genomic sequence. The computed hybridization energy for the structure shown is -59.6 
kcal/mole, with a net energy of -25.7 kcal/mole, after subtraction of unfolding energies of 10.0 and 
23.9 kcal/mole for the respective SePP1 and ZIKV RNA regions. The underlined region indicates the 
core of the antisense pairing of these two RNAs that was first identified by BLAST search as a 21/22 
identity plus/minus sequence match, which is substantially extended by IntaRNA into the intron at left. 
In Panel B, the predicted interaction between a region of the ZIKV non-coding “subgenomic flavivirus 
RNA” (sfRNA) and an intronic region of the human thioredoxin reductase 1 (TR1) pre-mRNA. For this 
analysis, the ZIKV ~300-base 3’UTR region was scanned vs. a 2000-base fragment (55001-57000) of 
the TXNRD1 genomic sequence.  The computed hybridization energy for the structure shown is -48.0 
kcal/mole, with a net energy of -24.8 kcal/mole, after subtraction of unfolding energies of 7.6 and 15.6 
kcal/mole for the respective TR1 and ZIKV RNA regions. The underlined region indicates the core of 
the antisense pairing of these two RNAs that was first identified by BLAST search as a 22/24 identity 





IntaRNA default input parameters used for all of the analyses in this 
study: 
 
Energy threshold for output                     0 
   Number of suboptimal interactions  0 
Seed Parameters 
   Min. number of basepairs in seed  7 
   Max. Number of mismatches in seed  0 
   Seed position (query)          not provided 
Folding Parameters 
   Temperature for energy computation  37.0 
   Folding window size target           150 
   Max. basepair distance (target)   100 
 
Figure A2: Raw data output for IntaRNA-predicted RNA-RNA interaction between a 3’ region of the ZIKV 
mRNA (polymerase coding region) and a region of SePP1 mRNA. A more extended version of this interaction, 







Figure A3:  Raw output data for IntaRNA-predicted RNA-RNA interaction between a 3’ region of the Zika 
virus mRNA (polymerase coding region) and a region of SePP1 pre-mRNA, spanning an intron/exon 
boundary in SePP1. For this analysis, a 500 base fragment of Zika virus (9,501-10,000) was scanned vs. a 2,000 
base fragment (8,001-10,000) of the SePP1 genomic sequence.   Add 9500 to the numbering shown below for the 
position in the Zika gene file GenBank KU321639.1, and add 8000 to the numbering shown below for the position 
in the SePP1 gene file GenBank DQ022288.1. The 2000 base SePP1 Sequence includes the entire 4th exon of only 
117 bases (where there is an antisense match between Zika and the SePP1 mRNA coding region), extended to 
include as much of the upstream and downstream introns as can be included in the 2000 base size limit for IntaRNA 
input. The same results are shown as Figure 3A in the main article, with the position numbering edited to correspond 





Figure A4: Raw data output for IntaRNA-predicted RNA-RNA interaction between a 3’ region of the ZIKV 
non-coding “subgenomic flavivirus RNA” (sfRNA) and an intronic region of the human thioredoxin 
reductase 1 (TXNRD1) pre-mRNA. The Zika 300 base 3’ UTR region was scanned vs. fragment 55001-57000 of 
the TXNRD1 genomic sequence using the IntaRNA program with default parameters.  The same results are shown 





























Figure A5: Original uncropped gel photo corresponding to Fig. 6 in the main article, showing target-specific 
in vitro DNA hybridization of the predicted ZIKV-SePP1 antisense pairing of Figure 5, by gel shift assay 
using DNA oligonucleotides. Lanes 1-6 are as described in the legend to Figure 1B. The additional lanes not 
included in Figure 1B are as follows, Lane 7: same as lane 4 but with a 2:1 ratio of viral to SePP1 DNA, giving two 
bands, dsDNA (higher bright band) and unpaired Zika (fainter lower band.). Lane 8: same as lane 4 but in the 
presence of sheared human cellular DNA. Lane 9: size marker for dsDNA, the relevant markers (from the lowest up) 























Figure A6: Original uncropped Western blot of SePP1 protein expression, visible at the 60 kDa mass level, 
under varied conditions corresponding to Figure 7 in the main article. Lanes 2, 3, 4 and 6 correspond to the 
labeled lanes shown and described in the legend to Figure 4A. Lane 5 below was a skipped lane while loading the 
gel due to a noticed imperfection in the well, and was cropped out of Figure 4A. Lane 6 corresponds to the 
HEK+ZIKV+Se sample. All lanes and protein samples were loaded and prepared as described in the Materials and 
Methods section in the main article as well as the legend to Figure 7.  This is one of 3 similar Western blots that 


















Table A1: Data analysis of ImageJ densitometry results for SePP1 expression. Top: Densitometry values from 
Western Blot analysis for the protein expression of SePP1 from each experimental condition. Data gathered from 
triplicate blots all containing the same amount of protein sample from each experimental condition. P-values 
generated by comparing SePP1 expression in experimental conditions (HEK+Se, HEK+ZIKV and HEK+ZIKV+Se) 
to the HEK only condition in a two-sampled, 2-tailed t-Test assuming unequal variance. SEM represents standard 
error of the mean. Percent change from HEK for each experimental condition was calculated using the average 



























HEK HEK+Se HEK+ZIKV HEK+ZIKV+Se 
Blot 1 42,200 63,800 0 0 
Blot 2 41,600 123,000 321 394 
Blot 3 46,800 53,600 484 854 
Average value 43,500 80,100 268 416 
SEM ±1,640 ±21,600 ±155 ±240 
P-value  0.23 0.0015* 0.0015* 
Percent change from 
HEK 




















Figure A7:  Original uncropped Western blots of TXNRD1 protein expression under varied conditions 
corresponding to Figure 8 in the main article. Lanes 2-5 below correspond to the labeled lanes shown in Fig. 8A. 
All lanes and protein samples were loaded and prepared as described in the Materials and Methods section in the 
main article as well as the legend to Figure 8A. This is one of 3 similar Western blots that were analyzed by 
















Table A2: Data analysis of ImageJ densitometry results for TXNRD1 expression. Top: Densitometry values 
from Western Blot analysis for the protein expression of TXNRD1 from each experimental condition. Data gathered 
from triplicate blots all containing the same amount of protein sample from each experimental condition. P-values 
generated by comparing TXNRD1 expression in experimental conditions (HEK+Se, HEK+ZIKV and 
HEK+ZIKV+Se) to the HEK only condition in a two-sampled, 2-tailed t-Test assuming unequal variance. SEM 
represents standard error of the mean. Percent change from HEK for each experimental condition was calculated 
using the average densitometry values for each condition. * indicates a p-value ≤0.05. 
Experimental condition HEK HEK+Se HEK+ZIKV HEK+ZIKV+Se 
Blot 1 55,800 40,600 7,290 8,350 
Blot 2 52,800 23,000 3,220 5,230 
Blot 3 30,900 21,200 2,940 4,510 
Average  46,500 28,300 4,480 6,030 
SEM ±7,850 ±6,190 ±1,410 ±1,180 
P-value  0.14 0.034* 0.036* 
Percent change from 
HEK 
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Figure A8: Uncropped Western blots of Beta-actin protein expression under varied conditions in triplicate. 
Both top panel and bottom panel blots are identical containing equal amounts of protein, ran under the same 
conditions, and containing the same amount of molecular weight marker standard control. All samples and blots 
were run identically as described in the Materials and Methods section of the main article. Lanes are assigned for the 
top panel as follows: Ln1: molecular weight marker, Ln2: HEK, Ln3: HEK+Se, Ln4: HEK+ZIKV, Ln5: 
HEK+ZIKV+Se, Ln6: HEK, Ln7: HEK+Se, Ln8: HEK+ZIKV, Ln9: HEK+ZIKV+Se. Lanes are assigned for 
bottom panel as follows: Ln1: molecular weight marker, Ln2: HEK, Ln3: HEK+Se, Ln4: HEK+ZIKV, Ln5: 










Table A3: Data analysis of ImageJ densitometry results for Beta-actin expression. Top: Densitometry values of 
Beta-actin expression across all experimental conditions. Data gathered from triplicate blots all containing the same 
amount of protein sample from each experimental condition. P-values generated by comparing Beta-actin expression 
in experimental conditions (HEK+Se, HEK+ZIKV and HEK+ZIKV+Se) to the HEK only condition using a two 
sampled, 2-tail t-Test assuming unequal variences. Bottom: Densitometry values from western blot analysis for the 
total protein expression of Beta-actin from each western blot. Data gathered from triplicate blots all containing the 
same amount of protein sample from each experimental condition. Western blot analysis of Beta-actin was 
performed as a western blot control to ensure the western blot protocol was effective and experimental results 
concerning SePP1 and TXNRD1 protein expression were a result of ZIKV infection and not a variable concerning 
the western blot techniques utilized in these experiments. No meaningful changes in Beta-actin expression occurred 
in any experimental condition. SEM represents standard error of the mean.  
Experimental 
condition 
HEK HEK+Se HEK+ZIKV HEK+ZIKV+Se 
Blot 1 758 804 1,040 1,310 
Blot 2 1,050 759 1,580 1,560 
Blot 3 1,500 991 2,060 716 
Average value 1,100 851 1,560 1,120 
SEM ±216 ±71.1 ±295 ±251 
P-value  0.38 0.28 0.79 
    
Blot number Total average Beta-actin 
expression for blot 
SEM 
Blot 1 978 ±127 
Blot 2 1,240 ±201 


















Table A4: RT-qPCR data analysis in quadruplicate for each experimental condition for SePP1, TXNRD1, 
and ZIKV RNA levels.  Lower Ct values indicate more starting material in the original RNA sample. All p-values 
were calculated using a two sampled, 2-tailed t-Test assuming equal variance. P-values in the 8th column were 
generated by comparing the quadruplicate Ct values for each experimental condition against the quadruplicate Ct 
values for the HEK only condition. P-values in the 9th column generated by comparing all Ct values for the 
HEK+Se experimental condition against the all Ct values for the HEK+ZIKV+Se condition. P-values in 10th 
column generated by comparing all Ct values for the HEK+ZIKV experimental condition against the all Ct values 
for the HEK+ZIKV+Se experimental condition. All Ct values are ROX normalized.    
Experiment 
condition 






      
HEK 22.16 19.22 24.28 16.65 20.58 ±3.3 
HEK+ZIKV 17.74 18.52 17.37 18.33 17.99 ±0.53 
HEK+Se 21.02 20.23 19.06 19.29 19.90 ±0.90 
HEK+ZIKV+Se 17.91 19.63 19.66 19.34 19.14 ±0.83 
TXNRD1 RNA 
levels 
      
HEK 17.24 19.44 22.57 19.96 19.80 ±2.2 
HEK+ZIKV 14.61 20.39 23.19 23.06 20.31 ±4.0 
HEK+Se 18.4 17.14 20.35 21.02 19.23 ±1.8 
HEK+ZIKV+Se 14.72 17.62 19.40 15.48 16.81 ±2.1 
ZIKV RNA levels       
HEK 29.15 29.03 27.09 27.22 28.12 ±1.1 
HEK+ZIKV 26.18 25.43 25.57 25.17 25.59 ±2.9 
HEK+Se 28.17 30.42 28.50 23.69 27.70 ±0.43 
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Figure B1: Beta-actin expression across all experimental conditions in triplicate. Beta-actin western blot 
probe was performed as a control to eliminate any variable in the execution of the experimental western blot 
probe for nef-GFP expression. All gels were prepared in the same way. Equal amounts of protein were loaded 
into each lane with 3 uL 10X loading dye and brought up to 30 uL with 1x PBS. Ln1: 2 uL molecular weight 
marker, ln2: HEK lysate, ln3: HEK lysate+Se, ln4: pnefStop, ln5: pnefStop+Se, ln6: pnefATI1, ln7: 
pnefATI1+Se, ln8:PAC, ln9: PAC+Se. Gels were imaged with an Odyssey CLx (LI-COR) gel imager excited at 
700 nm with emission measured at 720 nm with 84uM concentration on the highest quality setting. Top panel 
has a foreign object on the image which was an embedded fiber that merged to the nitrocellulose membrane 
during transfer but has no effect on the outcome of the western blots presented here. In bottom, a lane was 
skipped between lanes 5 and 6 due to an inconsistency in the well from the package. All beta-Actin expression 
comes to the 45 kdal line which is what is expected and no changes in expression of Beta-actin are observed. No 

















Figure B2: GFP expression across all experimental conditions. All gels were loaded identically and 
are as follows: Equal amounts of protein were loaded into each lane with 3 uL 10X loading dye and 
brought up to 30 uL with 1x PBS. Ln1: 2 uL molecular weight marker, ln2: HEK lysate, ln3: HEK 
lysate+Se, ln4: pnefStop, ln5: pnefStop+Se, ln6: pnefATI1, ln7: pnefATI1+Se, ln8:PAC, ln9: PAC+Se. 
In Panels A and C, a lane was skipped between the molecular weight ladder (ln1) and the HEK lysate 
(ln22) due to pipetting error. In Panel C, ln7: pnefATI1 and ln6: pnefATI1+Se. Gels were imaged with 
an Odyssey CLx (LI-COR) gel imager excited at 700 nm with emission measured at 720 nm with 
84uM concentration on the highest quality setting. All GFP expression comes to the 27 kdal line which 
is what is expected for GFP alone but the fused nef-GFP protein product was expected to have more of 








Blot 1 Blot 2 Blot 3 Average Standard 
Deviation 
P-value 
HEK 0 0 0 0 0  
HEK+Se 0 0 0 0 0  
pnefStop 0 0 0 0 0  
pnefStop+Se 0 0 0 0 0  
pnefATI1 0 0 0 0 0  
pnefATI1+Se 973 898 1,880 1,250 ±547 0.012* 
PAC 90,600 64,600 93,100 82,700 ±15,800  
PAC+Se 58,300 62,300 58,100 59,500 ±2,370  
Table B1: Image analysis values from western blot triplicates for the protein expression of GFP 
from each experimental condition. Data gathered from triplicate blots all containing the same amount 
of protein sample from each experimental condition. All samples for each experimental condition were 
generated from the same cell condition. Gels were scanned with an Odyssey CLx (LI-COR) gel imager 
excited at 700 nm with emission measured at 720 nm with 84uM concentration on the highest quality 
setting. Quantitative analysis of GFP expression was also performed using the Odyssey CLx (LI-COR) 
gel imager analysis software. P-values generated by comparing GFP expression in experimental 
conditions without selenium supplementation to experimental conditions with selenium 
supplementation. All p-values were generated by in a two-sampled, 2-tailed t-Test assuming unequal 












Figure C1: Gel optimization of amount and incubation time for Mung Bean Nuclease (MBN) 
digestion of single-strand M13mp18 DNA. (a) Digestion of 1.25 µg M13mp18 in the presence of 
different amounts of MBN as indicated. 10 units of MBN is required to fully digest the material. (b) 
Isolation of 60 bp dsDNA product from M13mp18 with MBN. Both the amount of MBN and 
incubation time were varied. M13mp18 annealed with 60 nt probe requires 10 units of MBN and 15 
mins of incubation at 30 o C to digest single strand regions. Full gels are shown in (c) and (d). Asterisk 


























Figure C2: Full gel showing isolation of multiple distinct products from M13mp18. Lane 1: ladder; 
lane 2: single-strand M13mp18; lane 3: M13mp18 fully digested by MBN; lane 4: isolated biotinylated 
products from M13mp18 using three DNA probes (50, 60, and 75 nt); lane 5: electromobility shift 
assay in the presence of MS when only the 60 nt probe is biotinylated; lane 6: electromobility shift 
assay in the presence of MS when all probes are biotinylated. Lanes 7, 9, and 11 show synthetic 50 nt 
dsDNA, 60 nt dsDNA, and 75 nt dsDNA, respectively. Their electromobility shift assays are shown in 





















Figure C3: Full gel showing isolation of two products of the same length from M13mp18. Lane 1: 
ladder; lane 2: single-strand M13mp18; lane 3: M13mp18 digested by MBN; lane 4: synthetic 
monobiotinylated 60 bp duplex construct; lane 5: synthetic monobiotinylated 60 bp duplex construct 
bound to MS; lane 6: two independent biotinylated 60 bp isolates; lane 7: electromobility shift assay in 
the presence of MS when only one 60 nt probe is biotinylated; lane 8: electromobility shift assay in the 
presence of MS when both 60 nt probes are biotinylated. The lanes marked with an asterisk are shown 

































Figure C4: Gel analysis of target isolation from full-length HIV-1B RNA. Left: isolation carried 
out under identical conditions used to isolate 60 bp target from M13mp18. Lane contents indicated at 
bottom (lane one shows a ladder). The product (anticipated position marked with green arrow) was 
digested along with unannealed probe (blue arrow) and single strand HIV-1B (red arrow). Right: MBN 
titration (amounts indicated) carried out against 10 μg HIV-1B RNA. Undigested RNA (red arrow) was 
observed below 1 U. 















Figure C5: Gel analysis of sequence isolation from full-length HIV-1B RNA. Lane 1: ladder; lane 
2: HIV-1B alone; lane 3: HIV-1B RNA after MBN digestion; lane 4: synthetic monobiotinylated 60 bp 
DNA construct, Lane 5: synthetic monobiotinylated 60 bp DNA construct bound to MS; lane 6: 
biotinylated 60 bp RNA/DNA heteroduplex isolated from full length HIV-1B RNA; and lane 7: 
biotinylated 60 bp RNA/DNA heteroduplex isolated from full length HIV-1B RNA bound to MS. The 












Figure C6: Gel optimization of probe required for efficient annealing to both M13mp18 DNA. (a) 
and HIV-1B RNA (b). Gels are cropped for easy comparison. Molar ratios indicated at bottom. 
Increasing amount of 60 nt probe yields higher relative intensity of the 60 bp dsDNA or RNA/DNA 
heteroduplex product (green arrows). The original gels are shown in (c) and (d) and the colors of 
asterisks indicate lanes shown in (a) and (b). 
